There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.
Type | HazMat fee for 500 gram (Estimated) |
Excepted Quantity | USD 0.00 |
Limited Quantity | USD 15-60 |
Inaccessible (Haz class 6.1), Domestic | USD 80+ |
Inaccessible (Haz class 6.1), International | USD 150+ |
Accessible (Haz class 3, 4, 5 or 8), Domestic | USD 100+ |
Accessible (Haz class 3, 4, 5 or 8), International | USD 200+ |
Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 145040-37-5 | MDL No. : | MFCD00871371 |
Formula : | C33H34N6O6 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | GHOSNRCGJFBJIB-UHFFFAOYSA-N |
M.W : | 610.66 | Pubchem ID : | 2540 |
Synonyms : |
TCV-116;Candesartan M1 Cilexetil
|
Chemical Name : | 1-(((Cyclohexyloxy)carbonyl)oxy)ethyl 1-((2'-(2H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-2-ethoxy-1H-benzo[d]imidazole-7-carboxylate |
Num. heavy atoms : | 45 |
Num. arom. heavy atoms : | 26 |
Fraction Csp3 : | 0.33 |
Num. rotatable bonds : | 13 |
Num. H-bond acceptors : | 10.0 |
Num. H-bond donors : | 1.0 |
Molar Refractivity : | 165.77 |
TPSA : | 143.34 Ų |
GI absorption : | Low |
BBB permeant : | No |
P-gp substrate : | No |
CYP1A2 inhibitor : | Yes |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | Yes |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | Yes |
Log Kp (skin permeation) : | -5.03 cm/s |
Log Po/w (iLOGP) : | 4.1 |
Log Po/w (XLOGP3) : | 7.03 |
Log Po/w (WLOGP) : | 6.32 |
Log Po/w (MLOGP) : | 4.81 |
Log Po/w (SILICOS-IT) : | 4.95 |
Consensus Log Po/w : | 5.44 |
Lipinski : | 3.0 |
Ghose : | None |
Veber : | 2.0 |
Egan : | 2.0 |
Muegge : | 2.0 |
Bioavailability Score : | 0.56 |
Log S (ESOL) : | -7.62 |
Solubility : | 0.0000145 mg/ml ; 0.0000000237 mol/l |
Class : | Poorly soluble |
Log S (Ali) : | -9.86 |
Solubility : | 0.000000085 mg/ml ; 0.0000000001 mol/l |
Class : | Poorly soluble |
Log S (SILICOS-IT) : | -9.34 |
Solubility : | 0.000000278 mg/ml ; 0.0000000005 mol/l |
Class : | Poorly soluble |
PAINS : | 0.0 alert |
Brenk : | 2.0 alert |
Leadlikeness : | 3.0 |
Synthetic accessibility : | 5.01 |
Signal Word: | Danger | Class: | 6.1 |
Precautionary Statements: | P501-P263-P260-P270-P202-P201-P264-P280-P308+P313-P405 | UN#: | 2811 |
Hazard Statements: | H360-H362 | Packing Group: | Ⅲ |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
67% | With water; In methanol; toluene; for 2 - 4h;Heating / reflux;Product distribution / selectivity; | Example 15: Deprotection without Acid; A solution of trityl candesartan c (TCS, 350 g, 410.3 mmol), toluene (1050 mL), methanol (2100 mL) and water (17.0 mL) was refluxed for about 2-4 h (HPLC control), the solvents were evaporated at 40-50 C/P<100 mbar to give a residue as a viscous oil, the residue was dissolved at 45-55 C in a mixture of Toluene/Methanol (1041g, 95: 5, w/w) to give a clear solution. The solution was cooled to (-5)- (20) C the solution was kept at this temperature for about 8-12 hr, the precipitated solids were filtered off, washed on the filter with cold Toluene (350 mL) to give a wet solid (295.8 g, 83.0%) 110 g of the wet solid were dried at 50C/10 mbar for 2-6 hr to give a wet white solid (94g (LOD= 15-25%) ). The wet white solid (43.75 g) was dissolved at 40-60 C in Ethanol Absolute (215-363 mL 6- 10V), the solution was filtered and returned to the reactor, then the solution was cooled to (-15)- (5) C and was kept at this temperature for about 2-24 hr. The precipitated solids were filtered off, washed with cold Ethanol Absolute (23-35 mL) to give wet solid which was dried at 50 C/10 mbar to constant weight to give cilexetil candesartan (21.5 g, 67 %). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
98% | With hydrogenchloride; In methanol; dichloromethane; at -14 - -12℃;Flow reactor; Large scale; | III.Distilled methylene chloride (58.8 kg) into the reaction vessel, added triphenyl candesartan cilexetil (10.0 kg, 11.72 mol) prepared in Step II, and 75 kg of methanol that was frozen in advance to turn cold salt on. The temperature was lowered to reduce the temperature of the kettle. -14C;Add 7% HCl methanol (34.5 kg, HCl 66.16 mol) frozen in advance to the kettle, keep the kettle temperature at -12C-13C, react for 3 hours, and monitor with TLC (dichloromethane:methanol=20:1). After completion of the reaction, 6% aqueous ammonia was added to adjust the pH of the organic layer to 5.5, 290 kg of water was further added, and the mixture was stirred for 10 minutes. The mixture was allowed to stand for separation, and the separated organic layer was dried over anhydrous sodium sulfate. The desiccant was removed by filtration, and the filtrate was recovered under reduced pressure at 35[deg.] C. to obtain a viscous product.Anhydrous ethyl ether (45kg) was added to the viscous material in the kettle and stirred at 12C for 20 minutes. A large amount of solids appeared, the stirring was stopped, the temperature was lowered to 0C, and the mixture was allowed to stand for 3 hours. The filter cake was filtered and the cake was dried at normal pressure for 12 hours. Crude candesartan ester 7.0 kg was obtained. Calculated according to the following formula, the yield of this step is 98%. |
96% | With iron(III) chloride; In methanol; dichloromethane; at 23℃; for 48h; | A detritylation reaction represented by the following formula was carried out.In a mixed solution of N-<strong>[170791-09-0]trityl candesartan cilexetil</strong> (1.00 g, 1.2 mmol; trityl group-containing compound) in methylene chloride (2 mL) and methanol (4 mL)Iron trichloride (0.02 g, 0.12 mmol) was added at 23 C. and stirred for 48 hours.Reaction conversion of N-<strong>[170791-09-0]trityl candesartan cilexetil</strong> was 100% by high performance liquid chromatography (HPLC) analysis.The resulting reaction solution was concentrated under reduced pressure, then, to the concentrated residue, acetone,Crystallization with addition of water and filtration gave candesartan cilexetil (yield 0.69 g, yield 96%) as a crystalline product.Analysis values of candesartan cilexetil obtained were as follows. |
95.23% | With methanol; zinc(II) chloride; In butanone; at 20 - 40℃; for 2.5h;Product distribution / selectivity; | Example/STEP 3; Preparation of 1-[[(cyclohexyloxy)carbonyl]oxy]ethyl 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]-1H-benzimidazole-7-carboxylate (i.e., Candesartan cilexetil); Example/Step 3-A; To a 2 L, three-necked round-bottomed spherical flask, equipped with a reflux condenser and a thermometer, are added 123.3 g of candesartan cilexetil trityl (144.5 mmol) prepared as described in example/step 1, zinc chloride (approximately 23.64 g, 173.4 mmol), methylethylketone (approximately 665 mL) and methanol (approximately 74 mL). The suspension was heated to approximately 40 C. (+/-2 C.) over approximately 15 minutes and maintained at this temperature for approximately 2 hours. The heating was stopped, and the resulting solution was cooled to approximately 20-25 C. over approximately 15 minutes. Deionized water (approximately 665 mL) and ammonium chloride (approximately 59.6 g) were then added to the yellow solution. The aqueous layer was then separated, and to the organic layer was added n-heptane (approximately 924 mL). The mixture was stirred at room temperature for approximately 24 hours. The suspension was then cooled to approximately 0-5 C. and was stirred at this temperature for approximately 2 hours. The suspension was then filtered, and the resulting solid was washed with n-heptane (2× approximately 103 mL) to yield 103.5 g (LOD=18.81%; 84.03 g (dry) 95.23% yield) of crude candesartan cilexetil. Table 6 illustrates the results of an HPLC analysis of the crude candesartan cilexetil obtained in Example/Step 3-A. |
95% | With montmorillonite K10 Clay; In methanol; dichloromethane; at 38 - 42℃; | (1) 409.2 mL of dichloromethane was sequentially added to a 1 L reaction flask.Trityl candesartan cilexetil (42.6 g, 0.050 mol),136.4 mL of anhydrous methanol and 13.6 g of montmorillonite,The temperature is raised to 38 ~ 42 C reflux reaction for 4 ~ 24h,The HPLC content <3.0% of <strong>[170791-09-0]trityl candesartan cilexetil</strong> was detected by HPLC until the end of the reaction.The reaction solution is filtered,The filter cake was washed with 68.2 mL of dichloromethane.The filtrates were combined and cooled to 20-25 C.Add 409.2mL of water,The pH was adjusted to 4.5 to 5.5 with 1% dilute hydrochloric acid and stirred for 10 min.After standing for 30 min, the separated organic layer was washed twice with 409.2 mL.(2) The organic layer was evaporated to dryness under reduced pressure.Add methyl tert-butyl ether (MTBE, 341.0 mL) preheated to 35-40 C,Add a little seed crystal, cool to 15 ~ 25 C for 10 h, filter.The obtained wet product was beaten with methyl tert-butyl ether (272.8 mL) at 15 to 25 C for 3 h.Filter and filter cake was washed with methyl tert-butyl ether (68.2 mL).The wet product is vacuum dried at 50-55 C.Candesartan cilexetil 46.4 g, yield 95%.The HPLC purity was 99.4%.(3) Recovery of methyl triphenyl methyl ether:The methyl t-butyl ether solution which was filtered out and washed in the previous step was evaporated to dryness under reduced pressure.Then 200 mL of methanol was added. Cooling to -10 C to precipitate crystals,Filter, wash with methanol and dry.Add 80 mL of heptane to 16 g of dry material.Then, thionyl chloride (6.4 ml) was added dropwise at room temperature.After stirring for 10 min, it was boiled for 20 hours.Half of the solvent was distilled off and the residue was stirred at room temperature for 6 hr then at 0 C overnight. The trityl chloride is filtered off and washed with heptane and used as it is.80% recovery of trityl derivatives from undeprotected starting materials |
94.6% | EXPERIMENT 6 (CANDESARTAN CILEXETIL)50 g of <strong>[170791-09-0]trityl candesartan cilexetil</strong> are dissolved in a mixture of 145 ml of dichloromethane and 125 ml of methanol. The solution is cooled to approximately 50C and a solution of 7.6 ml of methanesulfonic acid in 25 ml of methanol is added within 15 to 20 min. The mixture is stirred at approximately 3C for 60 min. The reaction mixture is then added to a mixture of 100 ml of dichloromethane, 190 ml of water and 88 ml of satrated NaHCO3 solution The pH ofthe mjxtture is adjusted to a pH of 6.4 to 6.5 with approximately 15 ml of saturated NaHCO3 solution and the mixture is stirred for approximately 15 min. Layers are separated and the aqueous layer is extracted with 100 ml of dichloromethane. The combined dichloromethane layers are separated and extracted with IOO ml of water. The solution is concentrated in vacuo to approximately I08 g. 100 ml of acetone are added and the mixture is again concentrated in vacuo to about 100 g. 15 ml of ethanol are added to the residue. Seeds of candesartan cilexetil are added and the suspension is stirred for approximately 3 hours at ambient temperature. 7. 5 ml of ethanol are added, the suspension is stirred for 1 hou.r and is then stored at 40C overnight. The suspension is warmed to room temperature and 350 ml of heptane are slowly added within 40 EPO <DP n="13"/>min. The suspension is stirred for 1 hour at ambient temperature and then for additional 3 hours in an ice bath. The product is then isolated by filtration, washed with 125 ml of heptane and dried in vacuum over night at ambient temperature.. Yiled 31 ,56 g (94,6%). | |
94% | With DIAION WK60L; In methanol; dichloromethane; for 12h;Reflux;Product distribution / selectivity; | One hundred ml of methanol and 100 ml of methylene chloride (MC) were added to 10 g of l-(cyclohexyloxycarbonyloxy) ethyl 2-ethoxy-l-((2'-(l-trityl-lH- tetrazol-5-yl) biphenyl-4-yl) methyl)-lH-benzo[d]imidazole-7-carboxylate(Pharmacostech), then to the reaction mixture was added 10 g of weak acidic resin (DIAION WK60L, Mitsubishi Chemical Co.), followed by refluxing for 12 hours. The solid components were filtered out from the reaction mixture and washed with 100 ml of methanol. The filter-in solution was cooled to 0C and the solid formed was removed by filtration, followed by concentration under vacuum. The obtained solid substance was dissolved into a small quantity of acetone. Then n-hexane was added to the acetone solution to obtain 6.73 g (yield rate: 94%) of the standard compound represent by the following Formula 7: 1H NMR (300 MHz, DMSOd6), delta 7.80 (d, IH, >6.02 Hz), 7.61-7.74 (m, 2H), 7.46-7.57 (m, 3H), 7.24 (m, IH), 6.92-7.05 (m, 4H), 6.83 (q, IH, Jt=5.31, 5.49 Hz), 5.49 (s, 2H), 4.56-4.66 (m, 3H),1 .82 (bs, 2H), 1.62 (bs, 2H), 1.05-1.46 (m, 13H). |
91% | EXAMPLE 3 Using 10.0 g of (+-)-1-(cyclohexyloxycarbonyloxy)ethyl 2-ethoxy-1-[2'-(N-triphenylmethyl-1H-tetrazol-5-yl)biphenyl-4-yl]methylbenzimidazole-7-carboxylate, the reaction and after-treatment of Example 1 was repeated except that ethanol was used in lieu of methanol. The procedure provided 6.83 g of (+-)-1-(cyclohexyloxycarbonyloxy)ethyl 2-ethoxy-1-[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methylbenzimidazole-7-carboxylate (yield 91%). In physicochemical properties, this compound was in agreement with the compound obtained in Example 1. | |
90.5% | Example 16: Deprotection without Acid; A suspension of <strong>[170791-09-0]cilexetil trityl candesartan</strong> (50.0 g, 58.62 mmol), water (2.64 g, 2.5 eq), and methanol (500 ml, 10 eq. by volume) was refluxed for about 16. 5 h to obtain a clear solution. The solvents were removed by evaporation at 30 mbar and 40C to obtain a solid residue (51. 7 g). The residue was dissolved at 60 C in a mixture of toluene/methanol (95: 5 w/w, 125 g), cooled to 20-23 C and stirred for about 15 h. A precipitate appeared and was collected by filtration, washed with a cold (4 C) mixture of toluene/methanol (95: 5 w/w, 25 g), and dried for 2 h at 50C and 30 mbar to give a crude solid candesartan cilexetil (32.41 g, 90.5 %), with 99.32% purity by HPLC. | |
86.8% | Example 17: Deprotection without Acid; A solution of Trityl Candesartan Cilexetil (100.0 g, 0. 117mol), Water (5.3 g), Toluene (600 mL) and Methanol (600 mL) was refluxed for about 10 h (HPLC in process control) and the solvents were evaporated at 60 C/30 mbar to obtain an oily residue. A part from the residue (6.84 g) was dissolved at 50 C in a mixture of Toluene/Methanol 95 : 5 (w/w), (11.2 g). A solution was stirred for about 6 h at 2-8'C, the solids were filtered off, washed with a cold mixture of Toluene/Methanol 95: 5 (w/w), (3.4 g) and dried at 60 C/30 mbar to the constant weight to give white solid (3.47 g, 86.8 %), 99.15 % pure by HPLC. | |
84% | Step 2: Preparation of candesartan cilexetil A mixture of N-<strong>[170791-09-0]trityl candesartan cilexetil</strong> (120 gm) in dichloromethane (720 mL) and methanol (360 mL) was taken in a round botton flask at ambient temperature followed by addition of formic acid (120 gm) over 5 minutes. The reaction mixture was heated to 30 C to 35 C and stirred at the same temperature for 7 hours. The reaction mixture was cooled to 15 C, and ethyl acetate (480 mL) and de-ionized water (480 mL) were charged to the reaction mixture; this was followed by pH adjustment with 10% aqueous sodium bicarbonate (1750 mL) at 15 C to 20 C. Ethyl acetate (120 mL) and de-ionized water (120 mL) were charged to the reaction and stirred for 20 minutes at the same temperature. The aqueous layer was extracted with ethyl acetate (2 X 240 mL) and ethyl acetate (240 mL) was added to the combined organic layer which was further washed with 20% aqueous sodium chloride. The organic layer was concentrated completely under vacuum at 25 C to 30 C and methyltertiarybutyl ether (120 mL) was added to remove the traces of ethyl acetate at the same temperature. Methyltertiarybutyl ether (480 mL) was added to the reaction mixture, stirred for 4 hours to 5 hours at ambient temperature, and cooled to 8 C to 12 C. The cooled reaction mixture was further stirred for 8 hours 12 hours, solid were filtered. The reaction mixture was washed with pre-cooled methyltertiarybutyl ether(120 mL) at 8 C to 12 C and dried under vacuum for 1 hour and further dried for 16 hours at 35 C to 40 C.Yield: 84%Chromatographic purity: 99.24%Desethyl candesartan cilexetil- 0.05 %Step 3: Purification of candesartan cilexetilCrude candesartan cilexetil (50 gm) was suspended in acetone (350 mL) at ambient temperature and stirred for 30 minutes at the same temperature. The resulting solution was filtered to remove insoluble particles and the obtained filtrate was warmed to 35 C to 40 C and de-ionized water (150 mL) was added at the same temperature. The resulting mass was slowly cooled to 2 C to 6 C in 1.5 hours and further stirred for 5 hours at the same temperature. The solid obtained was filtered, washed with chilled mixture of acetone:de-ionized water (2 X (35+35 mL)) and dried under vacuum at 35 C to 40 C to give pure candesartan cilexetil.Yield: 85% Chromatographic purity: 99.77%Desethyl candesartan cilexetil -NDThe candesartan cilexetil (30 gm) obtained above was heated in methanol (270 mL) in a round bottom flask at 35 C to 40 C and then cooled to 13 C to 17 C in 1 hour. The reaction mixture was stirred further for 7 hours and the solid was filtered and further washed with chilled methanol (12 mL). This was finally dried under vacuum at 35 C to 40 C for 16 hours.Yield : 88%Chromatographic purity: 99.90%Desethyl candesartan cilexetil -NDEthyl candesartan-0.076% | |
83 - 94% | With methanol; water; In toluene; for 4 - 4.5h;Heating / reflux;Product distribution / selectivity; | Example 1 A solution of <strong>[170791-09-0]trityl candesartan cilexetil</strong> (70 g, 82 mmol), toluene (210 ml), methanol (420 ml), and water (3.5 ml) was refluxed for about 4.5 hours. The clear solution was cooled, filtered, and the filtrate was returned to the reactor. Water (350 ml, 5 ml/g <strong>[170791-09-0]trityl candesartan cilexetil</strong>) was added, and the solution was stirred for a few minutes, giving two liquid phases after the mixing was stopped. The bottom phase (toluene, 225.5 g) was collected to a vessel, while the upper phase was left in the reactor. Toluene (70 ml, 1 ml/g <strong>[170791-09-0]trityl candesartan cilexetil</strong>) was added to the upper phase, and the solution was stirred for a few minutes, giving two liquid phases after the mixing was stoppedThe reactor was emptied from the methanol-water phase (now in the bottom), the toluene phase (80 g) was added to the first toluene phase, and the combined phase was returned to the reactor. The reactor was cooled to 0C, stirred for 16 hours, and filtered. The solids were washed with toluene (1 ml/g <strong>[170791-09-0]trityl candesartan cilexetil</strong>) to give 43.5 g on dry basis. Yield: 86% by weight; Example 2 EPO <DP n="7"/>A solution of trityl candosartan cilexetil (TCS, 70 g, 82 mmol), toluene (210 mL), methanol (420 mL) and water (3.5 mL) was refluxed for about 4 h. The clear solution was cooled and filtered. The filtrate was returned to the reactor and 2 volumes of water were added (140 mL). The solution was stirred for a few minutes, giving two liquid phases after the mixing was stopped. The bottom phase (toluene, 220.5 g) was collected to a vessel, while the upper phase was left in the reactor. 1 volume of toluene (70 mL) and 1 volume of water (70 mL) were added to the upper phase. The solution was stirred for a few minutes, giving two liquid phases after the mixing was stopped.The reactor was emptied from the methanol-water phase (now in the bottom) and the toluene phases (52 g) were added to the first toluene phase, and the combined phase was returned to the reactor. The reactor was cooled to 00C, stirred for 17 hours, and filtered. The solids were washed with 1 volume of toluene to give 47.5 g on dry basis. Yield: 94 % by weight; Example 3 A solution of <strong>[170791-09-0]trityl candesartan cilexetil</strong> (TCS, 50 g, 59 mmol), toluene (150 mL), methanol (300 mL) and water (2.5 mL) was refluxed for about 4.5 h. The clear solution was cooled and filtered. The filtrate was returned to the reactor and 2 volumes of water were added (10OmL). The solution was stirred for a few minutes, giving two liquid phases after the mixing was stopped. The bottom phase (toluene, 147 g) was collected to a vessel while the upper phase was left in the reactor. 3 volumes of toluene (150 mL) were added to the upper phase. The solution was stirred for a few minutes, giving two liquid phases after the mixing was stopped.The reactor was emptied from the methanol-water phase (now in the bottom) and the toluene phases (140 g) were added to the first toluene phase, and the combined phase was returned to the reactor. The reactor was cooled to 0C, stirred for 24 hours, and filtered. The solids were washed with 1 volume of toluene to give 27.9 g on dry basis. Yield: 83 % by weight. |
80% | Example 15. Obtaining candesartan cilexetil Methane sulphonic acid (62 mg) is added to a solution of cilexetil 2-ethoxy-l- [2 '- (trityl) -2H-tetrazole-5- yl) [ 1, 1 ' -biphenyl] -4-yl] methyl] - lH-benzimidazole-7- carboxylate (0.42 g) , which can be obtained from candesartan according to the method described in examples EPO <DP n="23"/>7 and 8 of European patent EP 459.136 Bl, in methylene chloride, keeping the temperature between -5 and 0C. Once the acid has been added, the ice bath is removed and the mixture is stirred for 2 hours at room temperature. When 5 the reaction is completed, cold water and methylene chloride are added and the pH of the resulting mixture is adjusted to approximately 6.3 with a solution of sodium bicarbonate in water 7% (p/v) . The aqueous phase is separated and extracted with methylene chloride. The10 organic phases are combined, washed with water and concentrated at reduced pressure. Acetone is added to the concentration residue and it is concentrated again at reduced pressure. The so obtained solid is recrystallised with ethanol/hexane, filtered and dried under vacuum at15 40C. (80% yield) . | |
78.6% | With formic acid; In methanol; toluene; for 10h;Heating / reflux;Product distribution / selectivity; | Example 7 Method of Deprotection using Formic Acid; A solution of <strong>[170791-09-0]trityl candesartan cilexetil</strong> (30 g, 0.035 mol) in toluene (180 ml), methanol (180 ml), and formic acid (1.6 g, 0.035 mol) was refluxed for about 10 h. The reaction was monitored using HPLC. Thereafter, the solution volume was reduced by evaporation under reduced pressure (30 mbar) at a temperature of about 55 C to 60C to obtain viscous oil (36.5 g). The oil was dissolved in a mixture of toluene: methanol (65.7g : 7.3 g), stirred at about 0C to 5C until crystallization started, and kept at 2C to 8C for about 20 hours. The solids were collected by filtration, washed on the filter with a mixture toluene/methanol (90: 10 w/w, 15 g), and dried under reduced pressure (10-50 mm Hg) at a temperature of about 50C to 55 C to yield candesartan cilexetil (16.88 g, 78.6 %) as a white powder. |
78.0% | With boric acid; In ethanol; at 25 - 30℃; for 8h;Heating / reflux;Product distribution / selectivity; | Step-3: Preparation of Cilexetil candesartan; Boric acid (9.0 g) is added to a suspension of Cilexetil trityl candesartan (wet wt, 180 g) in ethanol (1000 ml) at temperature of 25 - 300C, temperature of reaction mass is raised and maintained at reflux temperature for 8 hrs. Reaction mass is concentrated to one third of its original volume by distillation of solvent and cooled the solution to 25 - 3O0C. n-Hexane (500 ml) is added to the reaction mass, stirred for 8hrs at 25 - 3O0C and filtered the product. Wet cake is washed with n-hexane (100 ml) and dried the material at a temperature of 45- 5O0C till constant weight. Dry weight of Cilexetil candesartan is 70 g (Yield: 78.0%); Example 2: Preparation of Candesartan cilexetil (without isolation of <strong>[170791-09-0]cilexetil trityl candesartan</strong>); Carbohexyl 1-chloroethyl carbonate (36 g) is added to a suspension of trityl candesartan (100 g), potassium carbonate (24 g) and potassium iodide (12 g) in DMSO (500 ml) at <n="8"/>temperature of 60 - 65C over 30 min. Reaction mass is maintained at 60-650C for 2 hrs, added toluene (300 ml) and water (300 ml). Reaction mass is mixed for 15 min., allowed to settle, the layers are separated at 60 - 650C and aqueous layer is extracted with toluene (200 ml). Water (200 ml) washings are given to the combined organic layer and toluene extractions twice at temperature of 60 - 650C. Toluene is distilled off from water washed organic layer at temperature below 6O0C under vacuum, ethanol (100 ml) is added, mixed for about 30 min and distilled off solvents under vacuum at temperature below 6O0C under vacuum. Residue is cooled to 30 - 350C, ethanol (1000ml) and boric acid (9.0 g) is added at temperature of 25 - 300C, temperature of reaction mass is raised and maintained at reflux temperature for 8 hrs. Reaction mass is concentrated to one third of its original volume by distillation of solvent and cooled the solution to 25 - 3O0C.n-Hexane (500 ml) is added to the reaction mass, mixed for 8hrs at 25 - 3O0C and filtered the product. Wet cake is washed with n-hexane (100 ml) and dried the material at temperature of 45-500C till becomes constant weight. Dry weight of Cilexetil candesartan is 65 g (Yield: 72.5%) |
78% | With tin(ll) chloride; In methanol; dichloromethane; for 4h;Heating / reflux;Product distribution / selectivity; | Step 5: Detritylation; Reaction vessel is charged with tritylcandesartan cilexetil (21.0 g, 24.6 mmoi), methanol (63 mi), dichioromethane (250 ml), anhydrous tin (IS) chloride (3.35 g, 17.6 mmol) and heated at reflux temperature for 4h. Mixture is cooled to 3O0C, water (250 ml) and 1.57 g oxalic acid are added and the precipitate is separated. After that phases in filtrate are separated and organic phase is washed with water (2x250 ml). Organic phase is dried with magnesium sulphate (18 g) and then filtered and evaporated to oily residue (22 g), which is then dissolved in isopropyl acetate (60 ml) and stirred at room temperature for 3 h. Precipitate formed is filtered off and dried in vacuum drier at 45C for 2 h. Partly dried product candesartan cilexetil (1 1.7 g, 78%) is suspended for 1 h in terf-butyl methyl ether (107 ml), then filtered off and dried over night at room temperature. |
74% | In methanol; toluene; at 60 - 70℃; for 19h;Product distribution / selectivity; | Example 10: Deprotection without Acid; Cilexetil trityl candesartan (5.0 g, 5.86 mmol) was dissolved at 60C in toluene (30 ml). Methanol (30 ml) was added and the solution was heated in an oil bath to 70C for about 19 h. The volume of the solution was reduced at 50C to 60C under reduced pressure to a weight of about 16 g and then cooled to-10C for about 48 h. The precipitated solids were collected by filtration, washed with cold methanol (MeOH at about 0C to 5C ; 2 ml x 2), dried on the filter for about 1 h to give crude candesartan cilexetil (3.1 g, 88.5%). The crude candesartan cilexetil was dissolved at reflux in methanol (23 ml), the solution was filtered under reduced pressure, and cooled under stirring in an ice bath for about 3 h. White solids were collected by filtration, washed with methanol (2.5 ml x 3), and dried in the open air overnight to give candesartan cilexetil as a white solid (2.3 g, 74 %) with 99. 28% purity by HPLC. |
72% | A mixture of cilexetil trityl Candesartan in MDC was cooled at -10 to -5 C. A mixture of, methanol and hydrochloric acid was added to the reaction mixture at -10 to -5 C. and maintained for 3 hours. Sodium bicarbonate solution was added to the reaction mixture and organic layer was separated. Aqueous layer was extracted with MDC. Both organic layers were combined and washed brine solution. MDC was distilled out under vacuum to give residue. A mixture of rectified spirit and cyclohexane was added to the residue and stirred for 3 hours. The mixture was filtered and washed with mixture of rectified spirit and cyclohexane. The solid was dried to obtain Candesartan cilexetil.Purification of Crude Candesartan CilexetilA mixture of crude candesartan cilexetil, acetone and water was stirred at 55-60 C. The hot solution was filtered and filtrate was cooled at ambient temperature for 3 hours. The mixture was filtered and washed with mixture of acetone and water. The solid was dried to obtain pure Candesartan cilexetil.Yield: 68-72% | |
68 - 72% | Examples-5; Preparation of Candesartan cilexetil A mixture of cilexetil trityl Candesartan in MDC was cooled at -10 to -50C. A mixture of methanol and hydrochloric acid was added to the reaction mixture at -10 to -50C and maintained for 3 hours. Sodium bicarbonate solution was added to the reaction mixture and organic layer was separated. Aqueous layer was extracted with MDC. Both organic layers were combined and washed brine solution. MDC was distilled out under vacuum to give residue. A mixture of rectified spirit and cyclohexane was added to the residue and stirred for 3 hours. The mixture was filtered and washed with mixture of rectified spirit and cyclohexane. The solid was dried to obtain Candesartan cilexetil.Purification of crude candesartan cilexetil A mixture of crude candesartan cilexetil, acetone and water was stirred at 55-600C. The hot solution was filtered and filtrate was cooled at ambient temperature for 3 hours. The mixture was filtered and washed with mixture of acetone and water. The solid was dried to obtain pure Candesartan cilexetil.Yield: 68-72 % | |
66.4% | With formic acid; In methanol; dichloromethane; at 25 - 27℃; for 5h;Product distribution / selectivity; | Example 5: Method of Deprotection using Formic Acid; A solution of <strong>[170791-09-0]cilexetil trityl candesartan</strong> (2.0 g, 2.35 mmol), formic acid (2.16 g, 46.9 mmol), dichloromethane (8 ml) and methanol (4 ml) was stirred at 25 C to 27C for about 5 h (TLC monitoring). The reaction mixture was neutralized with a saturated solution of sodium bicarbonate. The dichloromethane was removed under reduced pressure, the residue was diluted with water (10 ml) and extracted with ethyl acetate (20 ml x 2). The combined organic layer was washed with brine (10 ml x 2), dried over sodium sulfate and evaporated to give an oil (2.05 g) which was crystallized from tert- butyl methyl ether (TBME) (2.7 g) to give Candesartan cilexetil (0.95 g, 66. 4 %). |
60% | With formic acid; In methanol; dichloromethane; at 30 - 35℃; for 5h; | To a mixtureof 1- (cyclohexyloxycarbonyloxy) ethyl 2-ethoxy-1- [ [2'- (N-triphenyl methyltetrazol-5-yl) [1, 1'-biphenyl] -4-yl] methyl]-lH-benzimidazole-7-carboxylic acid of Formula II (B) (50.0 gm) in methylene chloride (50.0 ml) and methanol (75.0 ml) was added formic acid (50.0 ml, 99%) slowly under stirring while maintaining the temperature below35 C. The resultant mass was stirred at30-35 C for further 5 hours. After completion of reaction, the reaction mass was cooled to about20 C and charged into a pre-cooled mixture of ethyl acetate (500.0 ml) and water (250.0 ml). The resultant reaction mixture was stirred for 30 minutes and layers were separated. The aqueous layers were combined and extracted with fresh ethyl acetate (125.0 ml). The combined organic layers were washed with sodium bicarbonate solution (10%,500. 0 ml) and finally with water (50.0 ml). The organic layer was dried over anhydrous sodium sulphate and to it was added activated carbon (2.0 gm, 4% w/w). After stirring for 30 minutes at20-25 C, it was filtered through a celite bed and the bed was washed with ethyl acetate (50.0 ml). The filtrate was concentrated to dryness under vacuum and at a temperature not exceeding 35-40 C. To the residue was added cyclohexane (500.0 ml) and the resultant mixture was stirred at25-30 C for 12 hours. The separated product was filtered and after washing with cyclohexane (50.0 ml), it was dried in a vacuum oven at a temperature of about35-40 C to afford crude candesartan cilexetil, which after first purification from acetone-water followed crystallization by from methanol gave pure title compound. Yield: 28. 0 gm (60%) HPLC Purity: 99.5% |
With methanesulfonic acid; In methanol; dichloromethane; at 25 - 27℃; for 4h;Product distribution / selectivity; | Example 3: Method of Deprotection using Methanesulfonic Acid; A solution of <strong>[170791-09-0]cilexetil trityl candesartan</strong> (0.50 g, 0.59 mmol), metlianesulfonic acid (0.09 g, 0. 88 mmol), dichloromethane (10 ml) and methanol (1 ml) was stirred at 25 C to 27C for about 4 h. The reaction was monitored using thin layer chromatography (TLC monitoring). The reaction mixture was neutralized with a saturated solution of sodium bicarbonate and the dichloromethane was removed under reduced pressure. The residue was diluted with water (10 ml) and extracted with ethyl acetate (20 ml x 2). The combined organic layers were washed with brine (10 ml x 2), dried over sodium sulfate, and evaporated to give Candesartan cilexetil crude. | |
With trifluoroacetic acid; In methanol; toluene; at 20 - 25℃; for 6.83333 - 21.5h;Product distribution / selectivity; | Example 8: Method of Deprotection using Trifluoroacetic Acid; The protecting group (trityl) was removed using strong organic acids. Trifluoroacetic acid (0.1 ml, 1.3 eq. ) was added at 20C to 25 C to a stirred suspension of <strong>[170791-09-0]cilexetil trityl candesartan</strong> (1 g) in methanol (6 ml) and toluene (6 ml). After 50 min of stirring at 20C to 25 C a solution formed. The solution was stirred at 20C to 25 C for about an additional 6 h. Thereafter, the pH of the solution was adjusted to 6.4 with a saturated aqueous solution of sodium bicarbonate, the solution was diluted with brine (20 ml), and extracted with ethyl acetate (20 ml x 2). The combined organic layers were washed with brine (10 ml), dried over sodium sulfate, filtered, and the volume reduced by evaporation to give a semi-solid mass crude candesartan cilexetil. Alternatively, trichloroacetic acid may be used with this process.; Example 9: Method of Deprotection using Trifluoroacetic Acid; Trifluoroacetic acid (0.17 g, 0.65 eq. ) was added dropwise at a temperature of about 20C to about 25C to a stirred suspension of <strong>[170791-09-0]cilexetil trityl candesartan</strong> (2 g, 2.34 mmol) in toluene (12 ml) and methanol (12 ml). A solution formed after 1.5 h of stirring and the solution was stirred for about 20 h at a temperature of about 20C to about 25C. t Thereafter, the pH of the solution was adjusted to a pH 6.5 with a saturated solution of sodium bicarbonate, diluted with water (30 ml), and extracted with ethyl acetate (20 ml x 4). The organic layers were collected and dried over sodium sulfate, filtered, and the solvent was removed by evaporation to yield semi-solid candesartan cilexetil. | |
With water; In methanol; toluene; for 5 - 12h;Heating / reflux;Product distribution / selectivity; | Example 12: Deprotection without Acid; A mixture of <strong>[170791-09-0]trityl candesartan cilexetil</strong> (20 g, 23.45 mmol), toluene (60 ml), methanol (60 ml), and water (1 ml) was gently refluxed for about 12 h. The reaction was monitored by HPLC. The solution volume was reduced by evaporation under reduced pressure (30 mbar) at a temperature of about 55C 60C to obtain viscous oil of candesartan cilexetil as a residue (36.5 g). | |
With water; In methanol; for 16 - 17h;Heating / reflux;Product distribution / selectivity; | Example 14 : Deprotection without Acid; A mixture of <strong>[170791-09-0]trityl candesartan cilexetil</strong> (20 g, 23.45 mmol), methanol (200 ml), and water (1 ml) was gently refluxed for about 16-17 h. The reaction progress was monitored by HPLC. The solution volume was reduced by evaporation under reduced pressure (30 mbar) at a temperature of 55C to 60C to obtain viscous oil of candesartan cilexetil as a residue. | |
With formic acid; In methanol; toluene; at 50 - 55℃; for 7h;Product distribution / selectivity; | Example 6: Method of Deprotection using Formic Acid; A solution of <strong>[170791-09-0]cilexetil trityl candesartan</strong> (1.0 g, 1.18 mmol) was dissolved in toluene (10 ml) at 50C to 55C followed by addition of formic acid (1.1 g, 23.88 mmol), and methanol (6 ml). The solution was heated to 50C to 5. 5"C for about 7 h. The reaction mixture was cooled to 20C to 25 C, pH adjusted to pH of 6.4 with 1 N NaOH, and extracted with ethyl acetate (20 ml x 3). The combined organic layers were washed with brine (10 ml x 2), dried over sodium sulfate and evaporated to give a semi-solid mass (0.79 g). | |
With pyridinium p-toluenesulfonate; In methanol; dichloromethane; at 25 - 27℃; for 20h;Product distribution / selectivity; | Example 4: Method of Deprotection using p-Toluene Sulphonic Acid; A solution of <strong>[170791-09-0]cilexetil trityl candesartan</strong> (0.50 g, 0.59 mmol), PPTS (pyridine para-toluene sulphonic acid, 0.22 g, 0.88 mmol), dichloromethane (10 ml) and methanol (1 ml) was stirred at 25C to 27C for about 20 h. The reaction progress was monitored using thin layer chromatography (TLC monitoring). The reaction mixture was neutralized with a saturated solution of sodium bicarbonate. The dichloromethane was removed under reduced pressure, the residue was diluted with water (10 ml) and extracted with ethyl acetate (20 ml x 2). The combined organic layers were washed with brine (10 ml x 2), dried over sodium sulfate, and evaporated to give Candesartan cilexetil crude. | |
Example 11: Deprotection without Acid; Cilexetil trityl candesartan (20 g, 23 mmol) was dissolved at 60C in toluene (120 ml). Methanol (120 ml) was added and the solution was heated in an oil bath at about 75C to 80C for about 13 hours. The solution was reduced in volume by evaporation at 50C to 60C under reduced pressure to give a viscous residue (about 27 g) which was dissolved in methanol (60 ml) and the solvent removed by evaporation to dryness to give a foam (about 23 g). The foam was dissolved in methanol (about 40 g) at reflux temperature. The solution was then filtered under reduced pressure, cooled to 4C to obtain a solid and kept at this temperature for 12 to 15 hours. The precipitated solids were collected by filtration, washed with the cold methanol at about 0C to 5C (20 ml x 2) and dried at 50C under vacuum to give candesartan cilexetil (15.5 g). Trituration of candesartan cilexetil (1 g) with toluene (5 ml) at 25 C to 27C during 1 h gave candesartan cilexetil (about 0.65 g). | ||
A solution of 300 ml of methanol and 7,6 ml of methanesulfonic acid is cooled to approximately 3C. 50 g of <strong>[170791-09-0]trityl candesartan cilexetil</strong> is added and the mixture is stirred at approximately 3C for 30 minutes. 24.4 ml of triethylamine are added at a rate that temperature does not exceed 10C. 1000 ml of heptane are added followed by 50 ml of H2O. The mixture is stirred for 10 min in an ice bath. The layers are then separated, the lower phase is extracted with 250 ml of heptane under ice cooling. The layers are again separated and the lower phase is warmed up to approximately 20C. 1 5 ml of 2 m HCl is added drop wise followed by seeds of candesartan cilexetil. The suspension is briefly stirred and 14.3 ml of 2 m HCl are added within approximately 60 min. The suspension is then stirred for additional 30 min and the product is then isolated by filtration, washed with 75 ml of a mixture methanol and H2O ( 3:1 v/v) and dried in vacuum at ambient temperature over night. | ||
EXPERIMENT 1 (CANDESARTAN CILEXETIL))3 g (0,0035 mol) of trityl candersartan cilexetil was dissolved in a mixture of 9 ml of dichloromethane and 9 ml of methanol. Then 0,1 ml of water and 0,02 ml (cca one drop) of methanesulphonic acid (MSK) was added. Reaction mixture was stirred at room temperature for one hour 30 minutes, then a mixture of 6,3 ml of dichloromethane and 12,12 ml of water was added. pH was adjusted to 6,3 with a saturated solution of sodium hydrogen carbonate, organic layer was concentrated to the rest of 6,4 g. Then 6,3 ml of acetone was added and evaporated to drieness.1 ml of ethanol was added to precipitate crystals. To the resulting mixture 22 ml of n- hexane were added and stirring was continued at room temperature for one hour. The separated crystals were filtered and washed with 10 ml of a mixture of ethanol : n-hexane = 1 :9. Product was dried at 6O0C to obtain raw product (1 ,98 g) which was crystallised from 19,8 ml of i-propanole to obtain pure candesartan cilexetil in Form 1. Yield: 1 ,64 g. | ||
EXPERIMENT 4 (CANDESARTAN CILEXETIL)3 g (0,0035 mol) of <strong>[170791-09-0]trityl candesartan cilexetil</strong> was dissolved in a mixture of 9 ml of dichloromethane and 9 ml of methanol then 0,1 ml of water and 0,036 ml of trifluoroacetic acid was added. Reaction mixture was stirred at room temperature for one hour and 30 minutes, then a mixture of 6,3 ml of dichloromethane and 12,12 ml of water was added. pH was adjusted to ph 6,3 with a saturated solution of sodium hydrogen carbonate, organic layer was concentrated to the rest of 6,4 g. Then 6,3 ml of acetone was added and evaporated to dryness. 1 ml of ethanol was added to precipitate crystals. To the resulting mixture 22 ml of n-hexane were added and stirring was continued at room temperature for one hour. The separated crystals were filtered and washed with 10 ml of a mixture of ethanol : n-hexane = 1 :9. Product was dried at 600C to obtain raw product (2,25 g), which was crystallized from 22,5 ml of i-propanol to obtain pure candesartan cilexetil in Form 1. Yield: 1 ,87g | ||
Reactor cooled bellow 5 0C is charged with 85,3 kg MeOH and 0,8 L water and 3,2 kg cone sulfuric acid, or equivalent of HCI, whereto above product is added. The suspension is mixed until the completion of the reaction. Thereafter the temperature is kept bellow 10 0C and 8,5 kg Threeethylamine and 21 ,6 L water are added. Product is washed with heptane and to the methanolic phase water is added, heated to 40-45 0C and upon cooling candesartan cilexetil is crystallized. A small amount of sulfuric acid may be added during the crystallization. | ||
With methanol; water; for 3 - 4h;Heating / reflux; | A solution of Trityl Candesartan Cilexetil (TCS, 1000 g, 1172 mmol), Toluene (3000 mL), Methanol (6000 mL) and Water (50 mL) was refluxed for about 3-4 h (HPLC control), the solvents were evaporated at 50C under reduce pressure to give a residue as a viscous oil. The residue was dissolved at 500C in a mixture of Toluene/Methanol (2960 g, 95:5, w/w). The mixture was then cooled to (-5)C to (5)C and kept at this temperature for about 12 h. The precipitated solids were filtered off, washed on the filter with cold Toluene (1000 mL) and then dried at 600C under reduced pressure to give crude candesartan cilexetil Form I (-600 g L.O.D = 17% ). | |
With methanol; water; zinc(II) chloride; In dichloromethane; for 5h;Heating / reflux;Product distribution / selectivity; | Example 2A mixture of 1.55 g (1.8 mmol) of <strong>[170791-09-0]trityl candesartan cilexetil</strong>, 5.4 ml of methanol, 22 ml of methylene chloride, 0.05 g (1.61 mmol) of ZnCl2 and 0.5 ml of water is stirred under reflux temperature for 5 h. The reaction mixture is analyzed (Area % HPLC: candesartan cilexetil: 76.3%, <strong>[170791-09-0]trityl candesartan cilexetil</strong>: 1.8 %, 2-oxo candesartan cilexetil: 0.7 %, ethyl ester of candesartan 0.09 %.) and cooled to room temperature. Then, to the mixture 36 ml of methylene chloride and 55 ml of water is added. The phases were separated and organic phase is washed with 2 x 55 ml of water. Organic phase is dried over Na2SO4, filtered and evaporated to the oily residue. This residue is dissolved in 1.6 ml of methylene chloride and then 16 ml of isopropyl acetate is added. The mixture is stirred at 0 0C for 24 h. The precipitated product is collected by filtration and dried. After that the product was suspended in 5 ml of tert-butyl methyl ether. The mixture is stirred for 2h. The product is collected by filtration and dried at 400C for 2h in vacuum drier (0.7 g) . Area % HPLC: Candesartan cilexetil: 99.6%, 2-oxo candesartan cilexetil: 0.00 %, ethyl ester of candesartan 0.08%. | |
With water; In acetonitrile; for 6 - 15h;Heating / reflux;Product distribution / selectivity; | Example 9; Candesartan cilexetil (VI); A mixture of <strong>[170791-09-0]trityl candesartan cilexetil</strong> (IV; 2 g), acetonitrile (20 ml), and water (5 ml) was refluxed for 9 h. Then, 15 ml was distilled off from the reaction mixture over 1 h, the concentration residue was cooled, and toluene (15 ml) was added. The lower layer was separated, the upper organic layer was concentrated by evaporating 12 ml of the solvent, and the mixture was cooled and allowed to stand in a refrigerator overnight. The precipitated portion was sucked off and dried in vacuo at 40 0C. 1.4 g of a white substance with an HPLC purity of 98.2 % was obtained. After crystallization from toluene a product was obtained having the meting point of 160-163 C (decomp.) and HPLC purity of 99.2 %. 1H NMR (250 MHz, CDCl3) delta: 1.13-1.50 (12H, m); 1.64 (2H, m); 1.79 (2H, m); 4.10-4.50 (3H, m); 5.62 (2H, d); 6.65-6.93 (7H, m); 7.27-7.28 (IH, m); 7.46-7.48 (IH, m); 7.56-7.59 (2H, m); 7.98- 8.02 (IH, m).; Example 10; Candesartan cilexetil (VI); A mixture of <strong>[170791-09-0]trityl candesartan cilexetil</strong> (IV; 2 g), acetonitrile (20 ml), and water (5 ml) was refluxed for 9 h. Then, 10 ml was distilled off from the reaction mixture over 1 h, the concentration residue was cooled, and ethyl acetate (10 ml) was added. 25 ml of the solvent was distilled off from the mixture, the same amount of ethyl acetate was added, and the mixture was cooled. The lower layer was separated, the upper organic layer was evaporated, the evaporation residue was dissolved hot in toluene (9 ml), and the solution was cooled and allowed to stand in a refrigerator overnight. The precipitated portion was sucked off and dried in vacuo at 40 0C. 1.5 g of a white substance with an HPLC purity of 98.7 % was obtained. After crystallization from toluene a product was obtained having the meting point of 161- 163 0C (decomp.) and HPLC purity of 99.0 %.; Example 11; Candesartan cilexetil (VI); A mixture of <strong>[170791-09-0]trityl candesartan cilexetil</strong> (IV; 2 g), acetonitrile (25 ml), and water (5 ml) was refluxed for 1O h. The reaction mixture was evaporated in vacuo, and the evaporation residue was dissolved hot in toluene (35 ml). The excluded water layer was separated, and the organic layer was concentrated to 15 ml at a normal pressure. The mixture was cooled and allowed to stand in a refrigerator overnight. The precipitated portion was sucked off and dried at 40 0C in vacuo. 1.4 g of a white substance with an HPLC purity of 98.5 % was obtained. After crystallization from cyclohexane a product was obtained having the meting point of 160- 163 C (decomp.) and HPLC purity of 99.4 %.; Example 12; Candesartan cilexetil (VI); A mixture of <strong>[170791-09-0]trityl candesartan cilexetil</strong> (IV; 2 g), acetonitrile (20 ml), and water (2 ml) was refluxed for 15 h. The reaction mixture was evaporated in vacuo, and the evaporation residue was dissolved hot in toluene (35 ml). The excluded water layer was separated, and the organic layer was concentrated to 15 ml at a normal pressure. The mixture was cooled and allowed to stand in a refrigerator overnight. The precipitated portion was sucked off and dried at 40 C in vacuo. 1.5 g of a white substance with an HPLC purity of 98.2 % was obtained. After crystallization from the mixture toluene/cyclohexane a product was obtained having the meting point of 160-163 C (decomp.) and HPLC purity of 99.4 %.; Example 14; Candesartan cilexetil (VI); A mixture of <strong>[170791-09-0]trityl candesartan cilexetil</strong> (IV; 5 g), acetonitrile (50 ml), and water (12.5 ml) was refluxed for 6 h. Then, 35 ml was distilled off from the reaction mixture over 2.5 h, the concentration residue was cooled, and toluene (35 ml) was added. The lower layer was separated, the upper organic layer was concentrated by evaporating 30 ml of the solvent, and the mixture was cooled and allowed to stand in a refrigerator overnight. The precipitated portion was sucked off and dried at 40 C in vacuo. 3.1 g of a white substance with an HPLC purity of 98.2 % was obtained. The crystals were boiled with toluene (30 ml) for 30 minutes and then stirred at room temperature overnight. A product was obtained having the meting point of 161-163 0C (decomp.) and HPLC purity of 99.5 %. | |
With water; In acetone; for 48h;Heating / reflux;Product distribution / selectivity; | Example 13; Candesartan cilexetil (VI); A mixture of <strong>[170791-09-0]trityl candesartan cilexetil</strong> (IV; 1 g), acetone (35 ml), and water (10 ml) was refluxed for 48 h. The reaction mixture was evaporated in vacuo, the evaporation residue was dissolved hot in toluene (20 ml), and 10 ml of an azeotropic mixture toluene/water was distilled off from the mixture. This process was repeated three times, and, after the last <n="16"/>distillation, the resulting concentrated solution was cooled and allowed to stand in a refrigerator overnight. The precipitated portion was sucked off and dried at 40 C in vacuo. 0.65 g of a white substance with an HPLC purity of 97.2 % was obtained. After crystallization from the mixture toluene/ethanol a product was obtained having the meting point of 160- 163 0C (decomp.) and HPLC purity of 99.6 %. | |
With methanol; zinc(II) chloride; In dichloromethane; for 4h;Heating / reflux; | 17.06 g (20 mmol) of trityf candesartan cilthetaxetil, 60 ml MeOH, 240 ml methylene chloride and 2.39 g (17.5 mmol) ZnCi2 are heated under reflux for 4 hours. After the reaction is completed, the reaction mixture is cooled to approximately 300C, 200 ml of water are added, the organic and the aqueous phase are separated and the organic phase is washed with 2 x 200 ml of water and dried with Na2SO4 until the water content is below 0.3%, and the volatile components are evaporated to yield 18 g of an oily residue. The oily residue obtained is dissolved in 60 ml of isopropyi acetate and the mixture is stirred at room temperature (between 15 and 25C) for approximately 7 hours. The precipitate is filtered and dried for 2 hours at 45C. 10.7 g of a partially wet product are obtained which are further suspended in 107 ml of tert- butyl methyl ether for 1 hour at room temperature. The product is dried overnight at room temperature. | |
With hydrogen;palladium 10% on activated carbon; In ethanol; toluene; at 20℃; under 760.051 Torr;Product distribution / selectivity; | Example 2; Mixture of toluene (600 ml) and ethanol (300 ml) was added to 1-(Cyclo hexyloxycarbonyloxy)ethyl-2-ethoxy-1-[[2'-(N-triphenylmethyltetrazole-5-yl) biphenyl-4-yl]methyl]benzimidazole-7-carboxylate (60 gm) and hydrogenated at room temperature with hydrogen at 1 atmospheric pressure in the presence of palladium on carbon (10%, 12 gm) until the hydrogen uptake was ceased. Filtered over celite bed, washed with a mixture of toluene (100 ml) and ethanol (50 ml), filtrate was collected and concentrated below 450C. A mixture of acetone (100 ml) and n-hexane (450 ml) was added, stirred at room temperature for 2 hours, cooled to O0C and stirred for 4 hours 30 minutes, filtered, washed with a mixture of acetone (10 ml) and n-hexane (90 ml) and dried to get crude candesartan cilexetil (39 gm, HPLC purity: 92%). | |
With methanol; iodine; at 20 - 58℃;Product distribution / selectivity; | Trityl candesartan cilexetil (10 gm, 0.0117moles) was added to a mixture of methanol (100 mL) and iodine (0.3gm, 0.001181 moles) in a round bottom flask and the resulting solution was stirred for 15 minutes at ambient temperature to get a clear solution. The mixture was heated to 57C to 58C and stirred for 4 hours to 5 hours at the sametemperature, followed by removal of the methanol under reduced pressure, to get the residual mass. The residual mass so obtained was dissolved in dichloromethane (60mL) and washed with a 5% aqueous sodium thiosulfate (lOOmL) solution followed by washing of the organic layer with de-ionized water (40 mL). The organic layer was dried over sodium sulfate and concentrated under reduced pressure to get the residual mass. This was followed by the addition of cyclohexane (lOOmL) and subsequent stirring for 12 hours at ambienttemperature. The solid obtained was filtered, washed with cyclohexane (20mL) and air dried at 40C to get crude candesartan cilexetil.Yield: 7.45 gm |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
In water; acetone; at 0℃;Reflux;Product distribution / selectivity; | Example/Step 3-C; To a 1 L, three-necked round-bottomed spherical flask, equipped with a reflux condenser and a thermometer, are added 110.2 g of <strong>[145040-37-5]candesartan cilexetil</strong> (126.4 mmol) obtained in example/step 3-B and acetone (approximately 338 mL). The suspension was stirred at reflux, and, after reaching reflux, water (approximately 180 mL) was added. Thereafter, the mixture was stirred at reflux for approximately 30 minutes. The suspension was then cooled to approximately 0-5 C. and stirred at this temperature for approximately 3 hours. The suspension was then filtered, and the resulting white solid was washed with water (2× approximately 34 mL) to yield 93.21 g (LOD=18.63%; 75.85 g (dry), 98.31% yield) of <strong>[145040-37-5]candesartan cilexetil</strong>. Table 8 illustrates the results of an HPLC analysis of the <strong>[145040-37-5]candesartan cilexetil</strong> obtained in Example/Step 3-C. | |
at 80℃; for 168h;Conversion of starting material; | Samples of <strong>[145040-37-5]candesartan cilexetil</strong> Form I containing different proportions of Form Il were prepared from the products obtained in Example 2 and Preparative Example 1. The samples were exposed to an accelerated stability test at a temperature of 8O0C for different time periods up to 9 days. Once the time period has elapsed, the samples were analyzed byHPLC for the determination of the content of impurities. <n="16"/>Impurities corresponding to the following retention times: 8.3, 10.4, 12.5, 14.1 and 16.4 minutes were identified in the HPLC chromatograms.The HPLC analysis of impurities was carried out in a HPLC system with UV detector (Waters Alliance), with a L1 -type column according to US Pharmacopeia nomenclature, at a temperature of 3O0C, with a flow rate of 1 ml/min, an injection volume of 10 mul, and an UV detector at 210 nm.The mobile phase was constituted by a mixture of solution A (v/v) (aqueous 0.1 % v/v trifluoroacetic acid buffer) and acetonitrile.During the analysis the mobile phase contained 45% of Solution A and 55% of acetonitrile, except for the period comprised from minute 15 to minute 25 wherein a mixture of 5% Solution A and 95% acetonitrile was used.The sample was prepared dissolving 0.2 mg of the sample in 1 ml of mobile phase.TABLE III shows the results of the accelerated stability test performed at a temperature of 8O0C for the shown period, corresponding to the products prepared in Example 2 (Form I), in Preparative Example 1 (Form II), and mixtures prepared with said products:TABLE III <n="17"/>(continued)The sum of the impurities refers to the sum of areas recorded in the HPLC chromatogram corresponding to the degradation impurities detected at the retention times above specified.It can be observed that the <strong>[145040-37-5]candesartan cilexetil</strong> Form I substantially free of Form Il prepared according to the process of the invention shows a good stability, while Form Il is itself unstable and generates a considerable amount of impurities when tested under conditions of accelerated stability.When increasing the proportion of <strong>[145040-37-5]candesartan cilexetil</strong> Form Il in the samples, it can be observed that the percentage of impurities produced in the accelerated stability test also increases. | |
at 80℃; for 120h;Conversion of starting material; | Samples of <strong>[145040-37-5]candesartan cilexetil</strong> Form I containing different proportions of Form Il were prepared from the products obtained in Example 2 and Preparative Example 1. The samples were exposed to an accelerated stability test at a temperature of 8O0C for different time periods up to 9 days. Once the time period has elapsed, the samples were analyzed byHPLC for the determination of the content of impurities. <n="16"/>Impurities corresponding to the following retention times: 8.3, 10.4, 12.5, 14.1 and 16.4 minutes were identified in the HPLC chromatograms.The HPLC analysis of impurities was carried out in a HPLC system with UV detector (Waters Alliance), with a L1 -type column according to US Pharmacopeia nomenclature, at a temperature of 3O0C, with a flow rate of 1 ml/min, an injection volume of 10 mul, and an UV detector at 210 nm.The mobile phase was constituted by a mixture of solution A (v/v) (aqueous 0.1 % v/v trifluoroacetic acid buffer) and acetonitrile.During the analysis the mobile phase contained 45% of Solution A and 55% of acetonitrile, except for the period comprised from minute 15 to minute 25 wherein a mixture of 5% Solution A and 95% acetonitrile was used.The sample was prepared dissolving 0.2 mg of the sample in 1 ml of mobile phase.TABLE III shows the results of the accelerated stability test performed at a temperature of 8O0C for the shown period, corresponding to the products prepared in Example 2 (Form I), in Preparative Example 1 (Form II), and mixtures prepared with said products:TABLE III <n="17"/>(continued)The sum of the impurities refers to the sum of areas recorded in the HPLC chromatogram corresponding to the degradation impurities detected at the retention times above specified.It can be observed that the <strong>[145040-37-5]candesartan cilexetil</strong> Form I substantially free of Form Il prepared according to the process of the invention shows a good stability, while Form Il is itself unstable and generates a considerable amount of impurities when tested under conditions of accelerated stability.When increasing the proportion of <strong>[145040-37-5]candesartan cilexetil</strong> Form Il in the samples, it can be observed that the percentage of impurities produced in the accelerated stability test also increases. |
Crude <strong>[145040-37-5]candesartan cilexetil</strong> (7gm) was suspended in acetone (60mL) at ambient temperature and stirred for 15 minutes at the same temperature. The resulting solution was filtered to remove insoluble particles and the obtained filtrate was warmed to 35C to 40C. This was followed by the addition of de-ionized water (22mL) at the same temperature. The resulting mass was slowly cooled to 2C to 6C and stirred for a further for 3 hours to 3.5 hours. The wet solid was again suspended in a mixture of acetone (47 mL) and de-ionized water (20 mL) at 35C to 40C. The resulting mass was slowly cooled to 8C to 12C and stirred further for 4 hours. The solid obtained was filtered, washed with chilled mixture of acetone:de-ionized water (20 mL, 1:1) and air dried at 40C to give pure <strong>[145040-37-5]candesartan cilexetil</strong>.Yield: 3.97gmChromatographic purity: 99.34%Desethyl <strong>[145040-37-5]candesartan cilexetil</strong>: 0.29% | ||
In methanol; at 40 - 60℃;Purification / work up; | Purification of <strong>[145040-37-5]candesartan cilexetil</strong><strong>[145040-37-5]Candesartan cilexetil</strong> contaminated with des-<strong>[145040-37-5]candesartan cilexetil</strong> (60 gm, HPLC Purity: 95%; 3.4% of des-<strong>[145040-37-5]candesartan cilexetil</strong>) as obtained example 3 was dissolved in methanol (480 ml) at room temperature and heated to 55 to 60C, stirred for 30 minutes to obtain solution. Distilled off methanol until about 240 ml of solvent left under vacuum at 50C and stirred for 2 hours at 40 to 45C. The reaction mass was cooled to room temperature and stirred for 30 minutes. The reaction mass further cooled to 0C and stirred for 1 hour, filtered. The solid obtained was dried at 50 to 55C for 6 hours to obtain 56 gm of <strong>[145040-37-5]candesartan cilexetil</strong>.<strong>[145040-37-5]Candesartan cilexetil</strong>: 98%;Des-<strong>[145040-37-5]candesartan cilexetil</strong>: 0.9%. | |
Purification / work up; | Example 1: Preparation of Candesartan Cilexetil; Crystalline <strong>[145040-37-5]candesartan cilexetil</strong> (300 g, Type C crystals) was dissolved in dichloromethane (300 ml) at 25 to 30C. The clear solution thus obtained was filtered through a bed of celite. The solvent was recovered under vacuum to get a residue. To this residue was added cyclohexane (2100 ml). The resultant mixture was stirred for 2 hours and then filtered. The wet cake was washed with cyclohexane (300 ml) and then dried. The dried product was dissolved completely in methanol (2700 ml) at 25 to 30C and stirred for 10 to 15 minutes. The clear solution thus obtained was filtered through a bed of celite. The clear filtrate was cooled to 13 to 17C and stirred at this temperature for a period of 6 to 8 hours. The reaction mass was filtered, washed with chilled methanol and dried to get title compound in the form of "Type C" crystals, in a yield of 253 g, assayed at 99.2% purity, and with Chromatographic purity by HPLC: 99.516%. Particle size: D (v,0.1) D (v,0.5) D (v,0.9) Mean 4.20 10.31 23.17 RSD% 0.14 0.16 0.55 |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
92.1% | With 5% palladium on barium sulphate; ammonium formate; In water; isopropyl alcohol; at 25℃; for 14h; | Example 6-7 Deprotection (0433) (0434) A mixture of BCAN (0.1 g, 0.14 mmol), ammonium formate (0.044 g, 0.69 mmol), 5% Pd-BaSO4 (0.0152 g, 5 mol %), isopropyl alcohol (1 mL, 10 vol) and water (0.6 mL, 6 vol) was stirred at 25 C. for 14 hr. The conversion yield of this reaction was 92.10%. |
80% | With 5% palladium on barium sulphate; ammonium formate; In water; isopropyl alcohol; at 25℃; for 14h; | Into a 5-mL one-neck flask were sequentially added 1d2d (0.1 g,0.14 mmol), ammonium formate (0.044 g, 0.69 mmol), 5% Pd/BaSO4(0.0152 g, 5 mol%), i-PrOH (1 mL) and H2O (0.6 mL) at 25 C. Aftercompletion of the reaction (14 h), EtOAc (10 mL) was added tothe mixture. The mixture was filtered through Celite, the filtratewas concentrated and the residue was purified by silica gel columnchromatography (hexane-EtOAc, 15:85) to give 2d as a colorlesssolid; yield: 0.068 g (80%) |
With ammonium formate;palladium over charcoal; In water; isopropyl alcohol; at 55 - 60℃; for 12 - 15h; | Residue was cooled to about 25-30Cfollowed by charging isopropyl alcohol (60 ml), water (40 ml), palladium-carbon(6.4 grams), and ammonium formate (11.6 grams). The resultant reactionsuspension was heated to about 55-60C and maintained for about 12-15 hours.The reaction mass was cooled to about 25-30C and was filtered on celite,washed the celite with isopropyl alcohol (20 ml). 585 ml of water was charged inanother round bottom flask and the filtrate was charged. pH was adjusted to about4-5 with 33 ml of acetic acid over about 30-45 minutes. Separated solid wasfiltered and washed with 25 ml of water followed by slurrying in 200 ml of water.Solid was filtered and washed with 25 ml of water. Wet solid was slurried in 78 mlof toluene and filtered, washed with 20 ml of toluene. Solid obtained was dried atabout 50-60C under vacuum for about 3-5 hours to yield 14.2 grams of titlecompound of Formula (I). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With potassium carbonate; In methanol; ethanol; water; N,N-dimethyl-formamide; | WORKING EXAMPLE 7 1-(Cyclohexyloxycarbonyloxy)ethyl 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]benzimidazole-7-carboxylate To a solution of 2-ethoxy-1-[[2'-(N-triphenylmethyltetrazol-5-yl)biphenyl-4-yl]methyl]benzimidazole-7-carboxylic acid (0.5 g) in DMF (5 ml) were added potassium carbonate (0.12 g) and cyclohexyl 1-iodoethyl carbonate (0.26 g). The mixture was stirred for one hour at room temperature. To the reaction mixture was added water and the mixture was extracted with ethyl acetate. The organic layer was washed with water and dried. After removal of the solvent, the residue was dissolved in methanol (10 ml) and to the solution was added 1N-HCl (2 ml). The mixture was stirred for one hour at room temperature. The reaction mixture was concentrated to dryness and the residue was partitioned between ethyl acetate and water. The organic layer was washed with water and dried. After removal of the solvent, the residue was purified by column chromatography on silica gel to give colorless powder (0.21 g, 47%), m.p. 103-106 C. To the powder (1 g) obtained as above was added ethanol (6 ml). The mixture was stirred for 3 hours at room temperature and allowed to stand under ice-cooling. The mixture was then stirred for one hour at temperatures not higher than 10 C. Resultant crystals were collected by filtration and washed with cold ethanol. The crystals were dried at 25 C. for 9 hours under reduced pressure, then at 35 C. for further 18 hours to obtain white powdery crystals (0.94 g), m.p. 158-166 C. (decomp.). 1 H-NMR (200 MHz) delta: 1.13-1.84(16H,m), 4.28-4.55(3H,m), 5.65(2H,d), 6.72(1H,q), 6.81(2H,d), 6.93(2H,d), 7.03(1H,t), 7.22-7.23(1H,m), 7.31-7.36(1H,m), 7.52-7.60(3H,m), 8.02-8.07(1H,m) IR(KBr) cm-1: 2942, 1754, 1717, 1549, 1476, 1431, 1076, 1034, 750 MS(m/z): 611 [M+H]+ |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
92% | EXAMPLE 1 In 29 mL of methylene chloride was dissolved 10.00 g of (+-)-1-(cyclohexyloxycarbonyloxy)ethyl 2-ethoxy-1-[2'-(N-triphenylmethyl-1H-tetrazol-5-yl)biphenyl-4-yl]methylbenzimidazole-7-carboxylate followed by addition of 23 mL of methanol and cooling to 5 C. Then, 6 mL of methanol containing 0.53 g of hydrogen chloride as dissolved was added dropwise at 5 C. over a period of 15 minutes. The mixture was further stirred at 5 C. for 3.5 hours, at the end of which time 19 mL of ethyl acetate and 19 mL of water were added. The mixture was adjusted to pH 6.3 with a saturated aqueous solution of sodium hydrogen carbonate and, then, 10 mL of ethyl acetate and 10 mL of 20% NaCl-H2 O were added. The aqueous layer was separated and extracted with 20 mL of ethyl acetate. The ethyl acetate layers were combined and redistributed into 20% NaCl and 38 mL of ethyl acetate. The organic layer was separated and concentrated and the residue was diluted with ethanol and reconcentrated. To the residue was added 20 mL of acetone and the mixture was stirred at room temperature for 3 hours for sufficient crystallization. Thereafter, 90 mL of hexane was added and the mixture was further stirred at room temperature for 1 hour and, then, under ice-cooling for 2 hours. The resulting crystals were collected by filtration and washed with 25 mL of acetone-hexane (1:9). The crystals were dried under reduced pressure to provide 6.90 g of (+-)-1-(cyclohexyloxycarbonyloxy)ethyl 2-ethoxy-1-[2'-(1H-tetrazol-5-yl) biphenyl-4-yl]methylbenzimidazole-7-carboxylate (yield 92%). 1 H-NMR (200 MHz, CDCl3) delta: 1.2-1.53 (12H, m), 1.69 (2H, m), 1.89 (2H, m), 4.55-4.69 (3H, m), 5.51 (1H, d), 5.61 (1H, d), 6.75-7.01 (11H, m), 7.13-7.46 (13H, m), 7.57 (1H, dd), 7.75 (1H, dd), 7.84-7.89 (1H, m) IR (KBr) cm-1: 2942, 1754, 1717, 1615, 1476 | |
In acetone; at 20℃; for 4h;Purification / work up; | Example 15; Candesartan cilexetil (VI); The crystals obtained by the method described in Example 14 were stirred with acetonitrile (15 ml) at room temperature for 4 hours. A product having HPLC purity of 99.3 % was obtained.; Example 16; Candesartan cilexetil (VI); The crystals obtained by the method described in Example 14 were purified by crystallization from acetonitrile (15 ml) and then by stirring at room temperature for 4 hours. A product having HPLC purity of 99.7 % was obtained. | |
In ethyl methyl ether; toluene; at 10℃; for 6h;Purification / work up; | Example 17; Candesartan cilexetil (VI); The crystals obtained by the method described in Example 14 were purified by crystallization from the mixture toluene/2-methoxyethane and then by stirring at 10 0C for 6 hours. A product having HPLC purity of 99.4 % was obtained. |
Alpha-Blockers-Examples of alpha-blockers, include, but are not limited to:Cardura (doxazosin)...Capoten (captopril)Lotensin (benazepril)Monopril (fosinopril)Prinivil and Zestril (lisinopril)Atacand (candesartan)Avapro (irbesartan)Benicar (olmesartan)Cozaar (losartan)... |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
75% | With sodium bicarbonate; In methanol; dichloromethane; water; ethyl acetate; | COMPARISON EXAMPLE 1 In 15 mL of methylene chloride was dissolved 5.44 g of (+-)-1-(cyclohexyloxycarbonyloxy)ethyl 2-ethoxy-1-[2'-(N-triphenylmethyl-1H-tetrazol-5-yl)biphenyl-4-yl]methylbenzimidazole-7-carboxylate followed by addition of 54 mL of methanol and 8.2 mL of 1N-HCl, and the mixture was stirred at 25 C. for 2 hours. Then, 19 mL of water and 19 mL of ethyl acetate were added and the mixture was adjusted to pH 3.2 with a saturated aqueous solution of sodium hydrogen carbonate. The mixture was extracted using 19 mL of water and 54 mL of ethyl acetate and the aqueous layer was separated and extracted with 30 mL of ethyl acetate. The organic layers were combined, washed with 40 mL of water and concentrated under reduced pressure to give an oil. This oil was purified by silica gel chromatography (300 mL, methylene chloride-methanol=10:1) to provide 2.92 g of (+-)-1-(cyclohexyloxycarbonyloxy)ethyl 2-ethoxy-1-[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methylbenzimidazole-7-carboxylate (yield 75%). The physicochemical properties of this compound were in good agreement with those of the compound obtained in Example 1. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
at 55℃; for 336h;Product distribution / selectivity; | Micronized candesartan (70 g, Sample 1) was slurried at 50C in absolute ethanol(420 mL, 6 vol.) for 31 hours. Thereafter, the precipitated solids were collected by filtration and dried at 6O0C under reduce pressure to yield micronized candesartan(Product) having desethyl-CNS in 0.05% w/w by HPLC.The starting micronized candesartan and the product candesartan were tested for stability in an oven at 55C for 2 weeks. Table 3 below summarizes the results. The values are reported as weight percent (w/w%) as determined by HPLC.Table 3. Micronized Candesartan Stability Test. EPO <DP n="14"/>Table 4 illustrates that the starting micronized candesartan partly decomposed to the IN-Et and 2N-Et products. | |
at 55℃; for 336h;Product distribution / selectivity; | An accelerated stability study shows that the active ingredient of the commercially available tablet Atacand is not stable. A sample of Atacand was submitted to a stability study. After 2 weeks at 550C, the impurity level of the tablet, namely the CNS desethyl (1-N-ethyl CNS and 2-N-ethyl CNS) significantly increased. The structures of the following impurities are as follows:The results are summarized in Table 4, the values in the table are by weight percent (w/w%) as determined by HPLC.Table 4: Stability results of Atacand 32 mg tablets (Xot No. 5289) at 550C EPO <DP n="15"/>*LTDL means less than detection limit |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
In ethanol; at 50℃; for 31h;Product distribution / selectivity; | Micronized candesartan (70 g, Sample 1) was slurried at 50C in absolute ethanol(420 mL, 6 vol.) for 31 hours. Thereafter, the precipitated solids were collected by filtration and dried at 6O0C under reduce pressure to yield micronized candesartan(Product) having desethyl-CNS in 0.05% w/w by HPLC.The starting micronized candesartan and the product candesartan were tested for stability in an oven at 55C for 2 weeks. Table 3 below summarizes the results. The values are reported as weight percent (w/w%) as determined by HPLC.Table 3. Micronized Candesartan Stability Test. EPO <DP n="14"/>Table 4 illustrates that the starting micronized candesartan partly decomposed to the IN-Et and 2N-Et products. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With hydrogenchloride; In methanol; ethanol; hexane; dichloromethane; water; acetone; | Reference Example 11 Production of (+-)-1-(cyclohexyloxycarbonyloxy)ethyl 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]-1H-benzimidazole-7-carboxylate [Compound B] To the solution of (+-)-<strong>[170791-09-0]1-(cyclohexyloxycarbonyloxy)ethyl 2-ethoxy-1-[[2'-(1-triphenylmethyl-1H-tetrazol-5-yl)biphenyl-4-yl]methyl]benzimidazole-7-carboxylate</strong> [Compound B(T)] obtained in Reference Example 10, were added methylene chloride (28 L) and methanol (161 L), and the solution was cooled to -5+-5 C. while stirring. To the solution was added dropwise methanolic hydrogen chloride (hydrogen chloride 4.4 kg dissolved in methanol 47 L) at 0 C. or less for 15+-5 minutes. The solution was stirred at -5+-5 C. for about 2 hours. To the reaction solution were added methylene chloride (209 kg) and pure water (303 L), and the pH of the solution was adjusted to pH about 6.3 at 5 C. or less with 7.0 w/v % sodium bicarbonate solution. The methylene chloride layer was separated, and the aqueous layer was extracted with methylene chloride (209 kg). The methylene chloride layers were combined and washed with water (157 L) and concentrated to 173 kg or less. To the residue was added acetone (124 kg), and the solution was concentrated to 154 kg. To the residue were added ethanol (24 L) and seed crystals, and the solution was stirred at room temperature for 3-5 hours to precipitate crystals. To the resulting mixture was added ethanol (12 L), and the solution was stirred at room temperature for about 30 minutes. To the mixture was added dropwise hexane (363 kg) for about 30 minutes, and the solution was stirred at room temperature for about 1 hour and then at 5+-5 C. for about 2 hours to precipitate crystals and age. The separated crystals were separated, washed with a mixture of ethanol-hexane (1:9) (247 L) and dried to give crude crystals of (+-)-1-(cyclohexyloxycarbonyloxy)ethyl 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]-methyl]benzimidazole-7-carboxylate [Compound B] (49.5 kg; 88.0%). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With methanol; for 24h;Heating / reflux;Product distribution / selectivity; | Comparative example 1 (WO 2005/021535, example 12)A mixture of <strong>[170791-09-0]trityl candesartan cilexetil</strong> (0.43 g) and methanol (8.6 ml) was stirred and refluxed for 24 h. After that time the reaction mixture was analyzed by HPLC. Candesartan cilexetil: 64.9 %Trityl candesartan cilexetil: 0.64 % 2-0xo candesartan cilexetil: 8.0 %The mixture was evaporated to 1/4 and after cooling the precipitated crystals were filtered. The filtrate was evaporated and crystallized from cyclohexane . The white crystals were obtained (HPLC Area %: candesartan cilexetil: EPO <DP n="18"/>76.1 %, <strong>[170791-09-0]trityl candesartan cilexetil</strong> : 1.2 %, 2-oxo candesartan cilexetil: 10.9 % | |
With methanol; formic acid; In dichloromethane; at 25℃; for 5 - 23h;Product distribution / selectivity; | Comparative example 2 (WO2005/037821 , example 5)A solution of <strong>[170791-09-0]trityl candesartan cilexetil</strong> (0.43g), formic acid (0.38 ml), methylene chloride (1.7 ml) and methanol (0.9 ml) was stirred at 25 0C for 5 h. The reaction mixture was analyzed after that time: HPLC area %, 5h: candesartan cilexetil: 68.1 %, <strong>[170791-09-0]trityl candesartan cilexetil</strong>: 12.4 %, 2-oxo candesartan cilexetil: 0.5 %HPLC area %, 7h: candesartan cilexetil: 64.6 %, <strong>[170791-09-0]trityl candesartan cilexetil</strong>: 14.9 %, 2-oxo candesartan cilexetil: 1.7 %HPLC area %, 23h: candesartan cilexetil: 61.6 %, <strong>[170791-09-0]trityl candesartan cilexetil</strong>: 18.4 %, 2-oxo candesartan cilexetil: 2.2 %. | |
Example 1The mixture of 0.43g (0.5 mmol) of <strong>[170791-09-0]trityl candesartan cilexetil</strong>, 15 ml of methanol, 0.05 g (0.37 mmol) of ZnCl2 and 0.4 ml of water is stirred under reflux temperature for 2.5 h. The reaction mixture is analyzed (Area % HPLC: candesartan cilexetil: 75.5 %, <strong>[170791-09-0]trityl candesartan cilexetil</strong>: 1.2 %, 2-oxo candesartan cilexetil: 1.6 %) and cooled to room temperature. Then, the mixture is neutralized to pH 6.11 by addition of a saturated solution of NaHCO3 and methanol is evaporated. Ethyl acetate (15 ml) and water (10 ml) are added and the mixture is stirred. After the separation of phases, the organic phase is washed with 10 ml of water. The organic phase is dried over Na2SO4, filtered and evaporated to 1/4 of the starting volume. To the oily remainder, 10 ml of heptane are added and cooled EPO <DP n="19"/>below 0 0C. The precipitated product is collected by- filtration and dried. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With triethylamine; for 1h;Heating / reflux; | Step 3 - Trityiation; Oily residue after cycloaddition (28.96 g), triethylamine (4 ml) and triphenySchloromethane (8.03 g, 28.8 mmol) are dissolved in dichloromethane (75.2 ml) and heated at reflux temperature for 1 h. After cooling the reaction mixture to room temperature silica gel (28 g) is added, stirred for a few minutes and slowfy <n="29"/>filtered off under minima. reduced pressure through filter for Pd/C, washed with dichioromethane and evaporated to oiiy product. Terf-butyl methyl ether (58 ml) is added and stirred at room temperature for 16 h. Precipitate formed was filtered off and washed with terf-butyl methyl ether, to yield (8.0 g, 50 % cycloaddition and tritylation together) solid tritylcandesartan cilexetil. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With azido tributyltin (IV); In toluene; for 52.5h;Heating / reflux; | Step 2 - CycSoaelditson; Flask is charged with 1 -(cyclohexyloxyicarbony.oxy)ethyl 1 -[(2'-cyanobiphenyl-4- yi)methyl]-2-ethoxy-1 /-/-benzo[c/]imidazol-7-carboxylate (17.8 g, 28.9 mmol) prepared according to present invention and tributyltin azide (19.2g, 57.8 mmol) in toluene (96 ml) and heated at reflux temperature. After 52.5 h reaction mixture is cooled and solvent is removed in vacuo to yield oily residue. Hexane (180 ml) is added, and stirred at room temperature for 1 h. Solvent is decanted. Product (29 g) crude candesartan cilexetil is obtained as an oil. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
To 50.0 grams (0.113 moles) of 2-ethoxy-1-[[2'-(1 H-tetrazol-5-yl)biphenyl-4-yl]-methyl]benzimidazole-7-carboxylic acid were added 250 ml of dry chloroformand 46 grams of triethylamine. Then, a solution of 25.5 grams tert-butyldimethylchlorosilane in dry chloroform was slowly added to the resultingsolution at ambient temperature and the mixture was stirred for 3 hours. Thereaction mass was cooled to 57C and 25.8 grams (1.1 moles) of 1-chloroethylcyclohexylcarbonate and 46 grams of triethylamine were added simultaneously, and the resulting mixture was stirred for 24 hours. The reactionmass was washed with aqueous saturated sodium bicarbonate solution followedby water, and the chloroform layer was separated and evaporated under reducedpressure. To the residue, diisopropyl ether was added and stirred to form acomplete solution. The ether solution was dried over magnesium sulfate and thesolvent was evaporated under reduced pressure. The precipitated solid wasfiltered and dried at 60C to get the product (+/-)-1-(cyclohexyloxycarbonyloxy)ethyl2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]benzimidazole-7-carboxylate. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
93.9% | With acetic acid; In ethyl acetate; at 30℃; | 30 g of the compound, 120 ml of ethyl acetate, 1 g of glacial acetic acid, and 41 g of tetraethyl orthocarbonate were added to the reaction flask, and the mixture was stirred and heated to 30 C, and the reaction was completed by TLC. The mixture was concentrated to a small volume under reduced pressure and cooled to 10 C for 3 hours. The mixture was filtered and dried to give a white solid (30.9 g,yield: 93.9%), and the purity of HPLC was 99.86%. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With hydrogen;palladium 10% on activated carbon; In methanol; toluene; at 20℃; under 2280.15 Torr;Product distribution / selectivity; | Preparation of candesartan cilexetilMixture of toluene (300 ml) and methanol (350 ml) was added to 1- (cyclohexyloxycarbonyloxy)ethyl-2-ethoxy-l-[[2'-(N-triphenylmethyltetrazole-5-yl) biphenyl-4-yl]methyl]benzimidazole-7-carboxylate (100 gm) as obtained example 2 and hydrogenated at room temperature with hydrogen at 3 atmospheric pressure in the presence of palladium on carbon (10%, 10 gm) until the hydrogen uptake was ceased. Filtered over celite bed, filtrate was collected and concentrated below 45C. Cyclohexane (1000 ml) was added to the residue and stirred for 6 hours at room temperature. The separated solid was filtered and dried to get 80 gm of candesartan cilexetil contaminated with des candesartan cilexetil.Candesartan cilexetil: 95%;Des-candesartan cilexetil: 3.4% |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
55% | With ammonium formate;5%-palladium/activated carbon; In water; isopropyl alcohol; at 40 - 50℃; for 17h; | Step 8 A mixture of the protected form by p-methoxybenzyl (compound 26a, 80.2 mg, 0.11 mmol), isopropanol (0.45 mL), water (0.3 mL), ammonium formate (36 mg, 0.57 mmol), palladium carbon catalyst (17 mg, 0.0033 mmol, Evonik, NN/W 5% Pd, water content 56%) was stirred at 40 C.-50 C. for 4 hr. Palladium carbon catalyst (13.5 mg, 0.0028 mmol, Evonik, NN/W 5% Pd, water content 56%) was added thereto, and the mixture was stirred at 50 C. for 1 hr. Then, palladium carbon catalyst (13.8 mg, 0.0029 mmol, Evonik, NN/W 5% Pd, water content 56%) was added thereto, and the mixture was stirred at 50 C. for 12 hr. After completion of the reaction, to the reaction mixture was added ethyl acetate, and the mixture was filtered. The filtrate was quantified by HPLC, and the content of the objective compound (compound 27, candesartan) was 36.8 mg (yield 55%). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
81% | In ethanol; at 20 - 45℃; for 5h; | Example 6.3 Crystallization in ethanol To a round-bottom flask equipped with magnetic stirrer containing nebivolol free base (500 mg, 1.23 mmol) and <strong>[145040-37-5]candesartan cilexetil</strong> (754 mg, 1.23 mmol) was added ethanol (12.5 mL) before heating at 45C. The resulting solution was seeded with the crystalline obtained in Example 2, cooled to room temperature and then stirred for 5 hours. The precipitated solid was filtered with a sintered funnel (porosity 3) furnishing an unstable solvate of EtOH. Then a drying under vacuum at 60C gave candensartan cilexetil - nebivolol (1:1) (salt) as a white solid (1.02 g, 81% yield).1H NMR [0144] Proton nuclear magnetic resonance analyses were recorded in deuterated dimethyl sulfoxide (DMSO) in a Varian Mercury 400 spectrometer, equipped with a broadband probe ATB 1H/19F/X of 5 mm. Spectra were acquired dissolving 5-10 mg of sample in 0.6 mL of deuterated solvent. [0145] 1H NMR (DMSO, 400 MHz): delta = 7.73 (d, J = 7.8 Hz, 1H); 7.58-7.50 (m, 1H); 7.44 (d, J = 7.8 Hz, 1H); 7.41-7.33 (m, 2H); 7.29-7.23 (m, 1H); 7.20 (t, J = 7.8, 1H); 7.00 (d, J = 9.2 Hz, 2H); 6.97-6.85 (m, 4H); 6.84-6.70 (m, 5H); 5.48 (s, 2H); 4.67-4.52 (m, 3H); 4.03-3.92 (m, 2H); 3.92-3.83 (m, 2H); 3.23-3.14 (m, 1H); 3.13-3.02 (m, 2H); 3.01-2.91 (m, 1H); 2.87-2.69 (m, 4H); 2.16-2.04 (m, 1H); 1.98-1.88 (m, 1H); 1.88-1.5 (m, 6H); 1.51-1.15 (m, 12H). IR [0146] FTIR spectrum was recorded using a Thermo Nicolet Nexus 870 FT-IR, equipped with a beamsplitter KBr system, a 35 mW He-Ne laser as the excitation source and a DTGS KBr detector. The spectrum was acquired in 32 scans at a resolution of 4 cm-1. [0147] The sample (KBr pellets) shows a Fourier Transform Infra Red spectrum with absorption bands at 3390 (m), 3059 (br), 2938 (m), 2861 (m), 1762 (s), 1549 (s), 1492 (s), 1215 (s), 1084 (m) cm-1. DSC [0148] DSC analyses were recorded with a Mettler DSC822e. A sample of 2.8160 mg was weighed into 40 muL aluminium crucible with a pinhole lid and was heated, under nitrogen (50 mL/min), at 10C/min from 30 to 300 C. [0149] The novel type of crystal of the present invention is characterized for one endothermic peak corresponding to the melting point at an onset 94.83 C (fusion enthalpy -25.15 J/g) (see figure 17). TGA [0150] Thermogravimetric analyses were recorded in a thermogravimetric analyzer Mettler TGA/SDTA851e. A sample of 4.1075 mg was weighed into a 70 muL alumina crucible with a pinhole lid and was heated at 10 C/min from 30 to 300 C, under nitrogen (50 mL/min). [0151] The TG analysis of the crystalline form according to the invention shows a weight loss at temperatures lower than the melting point. It corresponds to water loss (1.3% weight, 0.74 eq. H2O) (see figure 18). This loss of weight starts at room T and so the amount of water depends on the RH% of the atmosphere. XRPD [0152] XRPD analysis was performed using a Philips X'Pert diffractometer with Cu Kalpha radiation in Bragg-Brentano geometry. The system is equipped with a monodimensional, real time multiple strip detector. The diffractogram was recorded from 3 to 50 (2theta) at a scan rate of 17.8 per minute (see figure 19). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With Bis(p-nitrophenyl) phosphate; In dimethyl sulfoxide; acetonitrile; at 37℃; for 0.0333333h;pH 7.5;Enzymatic reaction; | The OM-, CC- andAM-hydrolase activities by recombinant human CES1 and CES2 weremeasured with 10-mM prodrugs as substrates (final solvent concentration:2.5% acetonitrile) with or without 1 mM BNPP (final solvent concentration:1% dimethyl sulfoxide) in triplicate. After 5-minute preincubation, the reaction was initiated by adding the substrate. The prodrugs were incubated in 50 mMTris-HCl buffer (pH 7.5, incubation volume of 0.2 ml) containing 5% (v/v)conditioned media from CES1- or CES2-overexpressed cells as an enzymesource at 37C for 2 minutes. The enzymatic activity was expressed asa metabolite formation rate per reaction (nanomole per minute per reaction)based on the production of respective metabolites. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
1.00 g | In tetrahydrofuran; at 5℃; for 6h;Inert atmosphere; | The mixture of 1 .87 ml of tetraethyl orthocarbonate, 0.6 ml of THF is cooled to 5C. Then I .25g of I-(((cyclohexyloxy)carbonyl)oxy)ethyl 2-(((2?-(l H-tetrazol-5-yl)-[l I ?-biphenyl]-4- yl)methyl)amino)-3-aminobenzoate dihydrochloride is added and the mixture is stirred under inert atmosphere at 5C for 6 hours. Then 2.4 ml of tert-butyl methyl ether is added and the suspension is stirred at 5C for 6 hours.HPLC purity: 97% m = l.OOgYield: 83%, from starting material ethyl 2-((ted-butoxycarbonyl)amino)-3-nitrobenzoate the yield is 66%. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
92.3% | Stage #1: C30H32N6O5*C2H2O4 With potassium carbonate In ethyl acetate at 10 - 15℃; Stage #2: orthocarbonic acid tetraethyl ester In acetic acid at 0 - 25℃; for 15h; | 4 Preparation of candesartan cilexetil 9g of oxalate compound 4, prepared according to the method of Example 3 Put 40g ethyl acetate into the reaction flask and control the temperature at 10-15,Undissolved, add 5% potassium carbonate aqueous solution dropwise to pH 6-7,Dissolve, stand still for layering, and wash the organic layer with 5g saturated brine.Add 5g anhydrous sodium sulfate and 0.5g activated carbon to the organic layer and dry it at 40-45.Decolorize for 1 hour, filter, remove the filtrate to dryness, add 15g of toluene,4.3g tetraethyl orthocarbonate, 1.3g acetic acid,Incubate for 12 hours at 20-25,Cool down to 05 and keep stirring for 3 hours,filter,The wet product is dried under reduced pressure at 45,8.5g crude candesartan cilexetil was obtained with a yield of 93%.Take 6.5g crude candesartan cilexetil,31g of acetone was put into the reaction flask and stirred,Raise the temperature to 40-45, keep stirring at 40-45 for 10 minutes,Filter while it is hot, and the filtrate is heated to 40-45,17.8g sodium bicarbonate aqueous solution (0.03g sodium bicarbonate dissolved in 17.8g water) preheated to 40-45 was added dropwise,The dripping time is 10-15 minutes, after dripping,Slowly lower the temperature to 30-35, keep the temperature at 30-35 and stir for 3 hours,Then lower the temperature to 05, keep stirring at 05 for 3 hours,Filter, get the wet candesartan cilexetil, and dry at 45,6.0 g of dry candesartan cilexetil was obtained, and the crystallization yield was 92.3%. |
Tags: 145040-37-5 synthesis path| 145040-37-5 SDS| 145040-37-5 COA| 145040-37-5 purity| 145040-37-5 application| 145040-37-5 NMR| 145040-37-5 COA| 145040-37-5 structure
Precautionary Statements-General | |
Code | Phrase |
P101 | If medical advice is needed,have product container or label at hand. |
P102 | Keep out of reach of children. |
P103 | Read label before use |
Prevention | |
Code | Phrase |
P201 | Obtain special instructions before use. |
P202 | Do not handle until all safety precautions have been read and understood. |
P210 | Keep away from heat/sparks/open flames/hot surfaces. - No smoking. |
P211 | Do not spray on an open flame or other ignition source. |
P220 | Keep/Store away from clothing/combustible materials. |
P221 | Take any precaution to avoid mixing with combustibles |
P222 | Do not allow contact with air. |
P223 | Keep away from any possible contact with water, because of violent reaction and possible flash fire. |
P230 | Keep wetted |
P231 | Handle under inert gas. |
P232 | Protect from moisture. |
P233 | Keep container tightly closed. |
P234 | Keep only in original container. |
P235 | Keep cool |
P240 | Ground/bond container and receiving equipment. |
P241 | Use explosion-proof electrical/ventilating/lighting/equipment. |
P242 | Use only non-sparking tools. |
P243 | Take precautionary measures against static discharge. |
P244 | Keep reduction valves free from grease and oil. |
P250 | Do not subject to grinding/shock/friction. |
P251 | Pressurized container: Do not pierce or burn, even after use. |
P260 | Do not breathe dust/fume/gas/mist/vapours/spray. |
P261 | Avoid breathing dust/fume/gas/mist/vapours/spray. |
P262 | Do not get in eyes, on skin, or on clothing. |
P263 | Avoid contact during pregnancy/while nursing. |
P264 | Wash hands thoroughly after handling. |
P265 | Wash skin thouroughly after handling. |
P270 | Do not eat, drink or smoke when using this product. |
P271 | Use only outdoors or in a well-ventilated area. |
P272 | Contaminated work clothing should not be allowed out of the workplace. |
P273 | Avoid release to the environment. |
P280 | Wear protective gloves/protective clothing/eye protection/face protection. |
P281 | Use personal protective equipment as required. |
P282 | Wear cold insulating gloves/face shield/eye protection. |
P283 | Wear fire/flame resistant/retardant clothing. |
P284 | Wear respiratory protection. |
P285 | In case of inadequate ventilation wear respiratory protection. |
P231 + P232 | Handle under inert gas. Protect from moisture. |
P235 + P410 | Keep cool. Protect from sunlight. |
Response | |
Code | Phrase |
P301 | IF SWALLOWED: |
P304 | IF INHALED: |
P305 | IF IN EYES: |
P306 | IF ON CLOTHING: |
P307 | IF exposed: |
P308 | IF exposed or concerned: |
P309 | IF exposed or if you feel unwell: |
P310 | Immediately call a POISON CENTER or doctor/physician. |
P311 | Call a POISON CENTER or doctor/physician. |
P312 | Call a POISON CENTER or doctor/physician if you feel unwell. |
P313 | Get medical advice/attention. |
P314 | Get medical advice/attention if you feel unwell. |
P315 | Get immediate medical advice/attention. |
P320 | |
P302 + P352 | IF ON SKIN: wash with plenty of soap and water. |
P321 | |
P322 | |
P330 | Rinse mouth. |
P331 | Do NOT induce vomiting. |
P332 | IF SKIN irritation occurs: |
P333 | If skin irritation or rash occurs: |
P334 | Immerse in cool water/wrap n wet bandages. |
P335 | Brush off loose particles from skin. |
P336 | Thaw frosted parts with lukewarm water. Do not rub affected area. |
P337 | If eye irritation persists: |
P338 | Remove contact lenses, if present and easy to do. Continue rinsing. |
P340 | Remove victim to fresh air and keep at rest in a position comfortable for breathing. |
P341 | If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing. |
P342 | If experiencing respiratory symptoms: |
P350 | Gently wash with plenty of soap and water. |
P351 | Rinse cautiously with water for several minutes. |
P352 | Wash with plenty of soap and water. |
P353 | Rinse skin with water/shower. |
P360 | Rinse immediately contaminated clothing and skin with plenty of water before removing clothes. |
P361 | Remove/Take off immediately all contaminated clothing. |
P362 | Take off contaminated clothing and wash before reuse. |
P363 | Wash contaminated clothing before reuse. |
P370 | In case of fire: |
P371 | In case of major fire and large quantities: |
P372 | Explosion risk in case of fire. |
P373 | DO NOT fight fire when fire reaches explosives. |
P374 | Fight fire with normal precautions from a reasonable distance. |
P376 | Stop leak if safe to do so. Oxidising gases (section 2.4) 1 |
P377 | Leaking gas fire: Do not extinguish, unless leak can be stopped safely. |
P378 | |
P380 | Evacuate area. |
P381 | Eliminate all ignition sources if safe to do so. |
P390 | Absorb spillage to prevent material damage. |
P391 | Collect spillage. Hazardous to the aquatic environment |
P301 + P310 | IF SWALLOWED: Immediately call a POISON CENTER or doctor/physician. |
P301 + P312 | IF SWALLOWED: call a POISON CENTER or doctor/physician IF you feel unwell. |
P301 + P330 + P331 | IF SWALLOWED: Rinse mouth. Do NOT induce vomiting. |
P302 + P334 | IF ON SKIN: Immerse in cool water/wrap in wet bandages. |
P302 + P350 | IF ON SKIN: Gently wash with plenty of soap and water. |
P303 + P361 + P353 | IF ON SKIN (or hair): Remove/Take off Immediately all contaminated clothing. Rinse SKIN with water/shower. |
P304 + P312 | IF INHALED: Call a POISON CENTER or doctor/physician if you feel unwell. |
P304 + P340 | IF INHALED: Remove victim to fresh air and Keep at rest in a position comfortable for breathing. |
P304 + P341 | IF INHALED: If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing. |
P305 + P351 + P338 | IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. |
P306 + P360 | IF ON CLOTHING: Rinse Immediately contaminated CLOTHING and SKIN with plenty of water before removing clothes. |
P307 + P311 | IF exposed: call a POISON CENTER or doctor/physician. |
P308 + P313 | IF exposed or concerned: Get medical advice/attention. |
P309 + P311 | IF exposed or if you feel unwell: call a POISON CENTER or doctor/physician. |
P332 + P313 | IF SKIN irritation occurs: Get medical advice/attention. |
P333 + P313 | IF SKIN irritation or rash occurs: Get medical advice/attention. |
P335 + P334 | Brush off loose particles from skin. Immerse in cool water/wrap in wet bandages. |
P337 + P313 | IF eye irritation persists: Get medical advice/attention. |
P342 + P311 | IF experiencing respiratory symptoms: call a POISON CENTER or doctor/physician. |
P370 + P376 | In case of fire: Stop leak if safe to Do so. |
P370 + P378 | In case of fire: |
P370 + P380 | In case of fire: Evacuate area. |
P370 + P380 + P375 | In case of fire: Evacuate area. Fight fire remotely due to the risk of explosion. |
P371 + P380 + P375 | In case of major fire and large quantities: Evacuate area. Fight fire remotely due to the risk of explosion. |
Storage | |
Code | Phrase |
P401 | |
P402 | Store in a dry place. |
P403 | Store in a well-ventilated place. |
P404 | Store in a closed container. |
P405 | Store locked up. |
P406 | Store in corrosive resistant/ container with a resistant inner liner. |
P407 | Maintain air gap between stacks/pallets. |
P410 | Protect from sunlight. |
P411 | |
P412 | Do not expose to temperatures exceeding 50 oC/ 122 oF. |
P413 | |
P420 | Store away from other materials. |
P422 | |
P402 + P404 | Store in a dry place. Store in a closed container. |
P403 + P233 | Store in a well-ventilated place. Keep container tightly closed. |
P403 + P235 | Store in a well-ventilated place. Keep cool. |
P410 + P403 | Protect from sunlight. Store in a well-ventilated place. |
P410 + P412 | Protect from sunlight. Do not expose to temperatures exceeding 50 oC/122oF. |
P411 + P235 | Keep cool. |
Disposal | |
Code | Phrase |
P501 | Dispose of contents/container to ... |
P502 | Refer to manufacturer/supplier for information on recovery/recycling |
Physical hazards | |
Code | Phrase |
H200 | Unstable explosive |
H201 | Explosive; mass explosion hazard |
H202 | Explosive; severe projection hazard |
H203 | Explosive; fire, blast or projection hazard |
H204 | Fire or projection hazard |
H205 | May mass explode in fire |
H220 | Extremely flammable gas |
H221 | Flammable gas |
H222 | Extremely flammable aerosol |
H223 | Flammable aerosol |
H224 | Extremely flammable liquid and vapour |
H225 | Highly flammable liquid and vapour |
H226 | Flammable liquid and vapour |
H227 | Combustible liquid |
H228 | Flammable solid |
H229 | Pressurized container: may burst if heated |
H230 | May react explosively even in the absence of air |
H231 | May react explosively even in the absence of air at elevated pressure and/or temperature |
H240 | Heating may cause an explosion |
H241 | Heating may cause a fire or explosion |
H242 | Heating may cause a fire |
H250 | Catches fire spontaneously if exposed to air |
H251 | Self-heating; may catch fire |
H252 | Self-heating in large quantities; may catch fire |
H260 | In contact with water releases flammable gases which may ignite spontaneously |
H261 | In contact with water releases flammable gas |
H270 | May cause or intensify fire; oxidizer |
H271 | May cause fire or explosion; strong oxidizer |
H272 | May intensify fire; oxidizer |
H280 | Contains gas under pressure; may explode if heated |
H281 | Contains refrigerated gas; may cause cryogenic burns or injury |
H290 | May be corrosive to metals |
Health hazards | |
Code | Phrase |
H300 | Fatal if swallowed |
H301 | Toxic if swallowed |
H302 | Harmful if swallowed |
H303 | May be harmful if swallowed |
H304 | May be fatal if swallowed and enters airways |
H305 | May be harmful if swallowed and enters airways |
H310 | Fatal in contact with skin |
H311 | Toxic in contact with skin |
H312 | Harmful in contact with skin |
H313 | May be harmful in contact with skin |
H314 | Causes severe skin burns and eye damage |
H315 | Causes skin irritation |
H316 | Causes mild skin irritation |
H317 | May cause an allergic skin reaction |
H318 | Causes serious eye damage |
H319 | Causes serious eye irritation |
H320 | Causes eye irritation |
H330 | Fatal if inhaled |
H331 | Toxic if inhaled |
H332 | Harmful if inhaled |
H333 | May be harmful if inhaled |
H334 | May cause allergy or asthma symptoms or breathing difficulties if inhaled |
H335 | May cause respiratory irritation |
H336 | May cause drowsiness or dizziness |
H340 | May cause genetic defects |
H341 | Suspected of causing genetic defects |
H350 | May cause cancer |
H351 | Suspected of causing cancer |
H360 | May damage fertility or the unborn child |
H361 | Suspected of damaging fertility or the unborn child |
H361d | Suspected of damaging the unborn child |
H362 | May cause harm to breast-fed children |
H370 | Causes damage to organs |
H371 | May cause damage to organs |
H372 | Causes damage to organs through prolonged or repeated exposure |
H373 | May cause damage to organs through prolonged or repeated exposure |
Environmental hazards | |
Code | Phrase |
H400 | Very toxic to aquatic life |
H401 | Toxic to aquatic life |
H402 | Harmful to aquatic life |
H410 | Very toxic to aquatic life with long-lasting effects |
H411 | Toxic to aquatic life with long-lasting effects |
H412 | Harmful to aquatic life with long-lasting effects |
H413 | May cause long-lasting harmful effects to aquatic life |
H420 | Harms public health and the environment by destroying ozone in the upper atmosphere |
Sorry,this product has been discontinued.
Home
* Country/Region
* Quantity Required :
* Cat. No.:
* CAS No :
* Product Name :
* Additional Information :